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Abstract
The purpose of this cross-sectional, secondary data analysis was to explore, non-modifiable
(stable) trait factors and modifiable (transient) state factors associated with fear of recurrence
(FOR) in breast cancer survivors. Antecedent trait factors included demographic, clinical,
social/behavioral factors, postulated mediator state factors included pain, fatigue, sleep
disturbances, depression, state anxiety and perceived stress, and FOR was the outcome variable.
The study used baseline data from an R-21 NCI funded (grant #R21CA109168) randomized
control trial that examined the effects of mindfulness based stress reduction in early stage breast
cancer recovery. Instruments from this study for antecedent variables (trait factors) included a
Demographic and Clinical History Form, STAI; instruments used for mediator variable (state
factors) included CES-D, STAI, PSS and MDASI subscales for pain and fatigue, sleep; the
instruments used for the outcome variable FOR - CARS overall fear and nature of worry. The
study sample included 82 women within 18 months post breast cancer treatment (stage 0, I, II,
III). The Theoretical Model for psychosocial nursing research was used as a heuristic framework
to examine the associations between trait factors and state factors and their mediating effects on
FOR. Aim 1 explored the relationship between the antecedent (trait) variables associated with
FOR (CARS overall fear and CARS nature of worry) using Pearson’s and Spearman’s
correlations and analysis of variance (ANOVA). The findings revealed a negative association
between age and FOR, CARS overall fear (r = -.236, p = .033) and FOR, CARS nature of worry
(r = -.269, p = .015). Trait anxiety was positively associated with FOR, CARS overall fear (r =
.433, p = .000) and FOR, CARS nature of worry (r = .358, p < 0.001). Race/ethnicity, education,
vii

marital status, employment, exercise, cancer stage, cancer treatment, exercise, smoking,
drinking, hormone use and family history of breast cancer were not associated with FOR. Aim
2 explored the relationship between postulated mediator (state) variables, such as pain, fatigue,
sleep disturbances, state anxiety, depression, perceived stress associated with FOR (CARS
overall fear and CARS nature of worry) using Pearson’s correlations. Findings revealed that
depression (r = .347, p = .001), state anxiety (r = .467, p < 0.001), perceived stress (r = .365, p =
.001) were positively associated with FOR, CARS overall fear of recurrence, and that pain (r =
.220, p = .047), fatigue (r = .247, p = .025), state anxiety (r = .369, p = .001), and perceived
stress (r = .410, p < 0.001) were positively associated with FOR, CARS nature of worry. Aim 3
used a mediation analysis (bootstrapping method) to examine the indirect effects of the
statistically significant modifiable mediator state factors on the statistically significant antecedent
trait factors and FOR (CARS overall fear and CARS nature of worry). With trait anxiety as the
antecedent variable, state anxiety was indirectly associated (a mediating variable) with FOR,
CARS overall fear (β = .1381, 95% CI = .0053 - .3050, p = .0299). Similarly, with a composite
age/trait anxiety antecedent variable, state anxiety was indirectly associated (a mediating
variable) with FOR, CARS overall fear (β = .5579, 95% CI = .1201 - 1.1669, p = .0157).
Perceived stress and depression did not mediate the relationship between age and trait anxiety
and concerns about recurrence overall fear. With trait anxiety as the antecedent variable,
perceived stress was indirectly associated (a mediating variable) with FOR, CARS nature of
worry (β = .5474, 95% CI = .0178 - 1.3298, p = .0294). Similarly, a composite age/trait anxiety
antecedent variable, perceived stress was indirectly associated (a mediating variable) with FOR,
CARS nature of worry (β = 2.0375, 95% CI = .1136 - 4.5976, p = .0495). Pain, fatigue and state
anxiety did not mediate the relationship between age and trait anxiety and FOR nature of worry.
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This study suggests that breast cancer survivors who are anxious at baseline and report a current
state of anxiety or perceived stress may be at higher risk for fears of breast cancer recurrence.
Understanding the individual patient characteristics such as age, history of anxiety and current
status of perceived stress or anxiety and the relationship with fears of recurrence allow nurses to
offer individualized interventions for patients at greatest risk for psychological distress.
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Chapter One
Introduction
Breast cancer is the second leading cause of cancer in women and survivors comprise the
largest population of cancer survivors in the United States (National Cancer Institute, 2013). In
2013 there were estimated to be 232,340 new breast cancer cases in women (National Cancer
Institute, 2013). There have been tremendous growth advancements in the screening, diagnosis
and treatment of breast cancer that has changed the trajectory of breast cancer management with
a major focus on survivorship. A factor contributing to improving the morbidity in breast cancer
survivorship is through optimal management of psychological health and well-being. The
psychological needs of breast cancer survivors vary across the disease and demographic
spectrum. However, one of the most prevalent and consistent psychological stressors is the everlooming fear of cancer recurrence (FOR). Although there have been advances in early diagnosis
and treatment of breast cancer, managing post-treatment psychological distress has proven to be
particularly challenging. The sequelae from the diagnosis and treatment of breast cancer and the
lingering threats of fear of cancer recurrence create long-term complications and impaired
quality of life for breast cancer survivors (Wong & Bramwell, 1992). The findings from this
study provides valuable data to assist health care providers with a better understanding of those
women who may be at greatest risk for worries about recurrence, the factors that are most
associated with fear of cancer recurrence and the effects of the interactions between those
factors.
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Statement of the Problem
The most current data from the National Cancer Institute 2009/2010 Progress Report
estimates 12 million cancer survivors in the United States in 2008 with breast cancer survivors
making up the largest population of 2.8 million survivors with 12.29% (or 1 in 8) of the women
born today will be diagnosed with some form of breast cancer in their lifetime (National Cancer
Institute, 2013). Breast cancer rates have increased since the early 1990’s, however in spite of
this, survival rates have continued to climb over the past 20 years partly due to advances in
breast cancer screening, early diagnosis and aggressive treatment modalities (National Cancer
Institute, 2013). During 2004-2008, the median age at the time of breast cancer diagnosis was
61 years indicating that 50% of women who developed breast cancer were 61 years of age or
younger at the time of diagnosis (Howlader et al., 2011). According to the American Cancer
Society (2012), women with breast cancer have an 89% survival rate after 5 years of diagnosis,
82% after 10 years and 77% after 15 years. Thus, the majority of breast cancer patients survive
an extended period of time after treatment. Since 1975, the breast cancer 5-year relative survival
rate has increased significantly for both African American and Caucasian women with a survival
rate of 77% for African American women and 90% among White women (Howlader et al.,
2011). The survival rate for women diagnosed before age 40 is 84% and 90% in women
diagnosed after age 40 (American Cancer Society, 2012). Breast cancer patients from lowerincome areas have lower 5-year survival rates than those from higher-income areas at every stage
of diagnosis (Harper et al., 2009).
The diagnosis and treatment of breast cancer along with the side effects of pain, fatigue
and anxiety and the lingering threats of fear of cancer recurrence create dysregulation of
psychological and physiologic mechanisms (Luecken & Compas, 2002; McGregor & Antoni,
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2009; Reich, Lesur & Perdrizet-Chevallier, 2008). About 30-40% of patients experience elevated
symptoms of anxiety and depression at the time of breast cancer diagnosis and although some of
these symptoms dissipate over time, there is a subset of women who continue to experience
psychological distress throughout their treatment and recovery, with 3-30% continuing to exhibit
signs of moderate to severe emotional distress (Andrykowski, Cordova, Studts, & Miller, 1998;
Carver et al., 1993; Cordova et al., 1995; Epping-Jordan et al., 1999; Luecken & Compas, 2002;
Reich, et al., 2008). This is an important finding because much of the earlier research has
focused on early intervention to address distress in the acute phase of breast cancer treatment but
interventions for fear of recurrence has long-term implications requiring more long-term
interventions (Lengacher et al., 2009). The previous emphasis on early detection, different
treatment modalities and cancer prevention has led to increased survivorship therefore
warranting current and future research efforts to focus on the physical, psychological and
economic factors associated with quality of life and well-being in survivorship (Baker,
Denniston, Smith & West, 2005).
Non-Modifiable Trait Factors Associated with FOR
Age is the one factor that is consistently described in the literature as being strongly
associated with fear of recurrence. The relationship of age and fear of recurrence was found to
be a common theme throughout the literature however, the parameters that define younger and
older patients varies greatly throughout the reviewed literature. Younger age (< 40 years) was
found to have more intense fears of cancer recurrence than women who were diagnosed at an
older age (>40 years) (Costanzo et al, 2007; Simard & Savard, 2009; Van den Beuken-van
Everdigen et al., 2008; Vickberg, 2003; Wade, Nehmy & Koczwara, 2005; Waljee et al., 2008).
This may be partly due to the slightly lower 5-year survival rate and the severity of the cancer
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diagnosis earlier than age 40; with this comes a greater sense of loss due to work opportunities,
childbearing, raising children and lost future opportunities (Wade et al., 2005).
Vickberg (2003) discovered that younger age was the strongest predictor of fear of
recurrence and the greatest predictor of distress of fear of recurrence for ages 32-47 years (p <
0.001) (Costanzo et al., 2007). This is consistent with other studies that identified age as a factor
related to adjustment in older women who reported less fear of recurrence (p<0.05) at 1-year
(Stanton, Danoff-Burg, & Burg, 2002); and at time of diagnosis and at their 2-year follow-up
than the younger breast cancer survivors (Liu et al., 2011; Van den Beuken-van Everdingen et
al., 2008).
Modifiable State Factors Associated with Fear of Recurrence
Triggers of fear of breast cancer recurrence were consistent among the reviewed studies.
Of all the triggers identified, pain was reported to be the most frequent trigger for fear of cancer
recurrence in breast cancer survivors (Gil et al., 2004; Mast, 1998; Mishel, Germino, & Gil,
2005; Van den Beuken-van Everdigen et al., 2008). Mishel et al., (2005) studied the efficacy of
an uncertainty management intervention in 509 North Carolina Caucasian and AfricanAmerican, older, long-term breast cancer survivors (5-9 years survivorship) and found that the
threat of recurrence endures over time. These women reported at least two physical or emotional
triggers per month (16 triggers over the course of the 8 months); although the reminders were not
constant they persisted over time and the cancer awareness remained continually in their
consciousness (Mishel et al., 2005).
Fear of Recurrence
One of the major causes of distress in breast cancer survivors is uncertainty of the future
or fear of cancer recurrence (Lee-Jones, Humphries, Dixon, & Hatcher, 1997; Wong &
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Bramwell, 1992). Fear of cancer recurrence can be the cause of distress in survivors or it can be
the end result of a variety of post-cancer related stressors. Several studies support this theory and
suggest that there is a bidirectional relationship between fear of cancer recurrence and emotional
distress; in some cases distress (anxiety, depression, fatigue) may precipitate fear of recurrence
(Lebel, Rosberger, Edgar, & Devins, 2009; Lee-Jones et al., 1997) or perhaps fear of recurrence
may precipitate the distress (Black & White, 2005; Deimling et al., 2006). Regardless of the
direction of the pathway several studies have reported a high prevalence of moderate to high fear
of recurrence. Vickberg (2003) reported a fear of recurrence prevalence of 55% (n=169) among
breast cancer survivors. Van den Beuken-van Everdingen et al. (2008) found 56% (n=136) up to
4 years post treatment and in an earlier study of survivors 5 years after diagnosis, as many as
70% of breast cancer survivors continued to have fears of cancer recurrence (Mast, 1998). Most
breast cancer survivors reported moderate cancer related anxiety, concerns about ongoing
physical symptoms and fear of cancer recurrence as their top sources of distress during multiple
points in their treatment and beyond (as far out as 2-years) (Costanzo et al., 2007; Liu et al.,
2011; Stephens et al., 2008). Lee-Jones et al. (1997) identified several precipitating factors that
influence fear of recurrence. These factors included the survivor’s perspective that periods of
emotional distress may directly impact their cancer recurrence, due to symptoms of fatigue or
pain interpreted as signs of cancer recurrence, or emotional distress which may heighten the
patient’s sensitivity to their physical symptoms resulting in fear of recurrence (Lee-Jones et al.,
1997). Connell, Patterson, and Newman (2006) reported that fear of recurrence was a major
concern for many of their study participants (54%) and a top concern among younger women <
41 years (31.5%). With the numbers of breast cancer survivors continuing to grow, it is
imperative to understand the factors that will influence breast cancer survivorship. Stress, both
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physical and psychological, are critical factors influencing the immunity in breast cancer quality
of life and morbidity (Andersen et al., 2008; Chrousos, 2000; Keicolt-Glaser, McGuire, Robles,
& Glaser, 2002; Witek-Janusek, Gabram, & Mathews, 2007). Considerations identified also pose
valuable questions regarding the need to identify a standardized definition for clinical levels of
fear of recurrence, defining pathological characteristics and levels for fear of recurrence, routine
screening and identifying indicators for clinical interventions (Thewes et al., 2012).
The findings from this study provide valuable data to support the understanding of those
factors most associated with fear of recurrence, particularly those factors that have the potential
mediating effect on fear of recurrence. Outcomes from this research can support future studies
that will focus on bio-behavioral associations with fear of recurrence, stress related biomarkers
and the effects of early screening and interventions. This is consistent with the recommendations
from a study performed by Lebel et al., (2009) suggesting that future research should evaluate
the prevalence of comorbid disorders (anxiety, depression, perceived stress) in cancer patients
who report high fear of recurrence.
Purpose of the Study
The purpose of this study was to examine the antecedent, non-modifiable (stable) trait
factors most associated with fear of breast cancer recurrence and the mediating effects of
modifiable (transient) state factors associated with fear of cancer recurrence. This study, a
secondary data analysis, used baseline data from an R-21 NCI funded (grant #R21CA109168)
randomized control trial that examined the effects of mindfulness based stress reduction in early
stage breast cancer recovery (Lengacher et al., 2009). The first aim was to examine the
relationship between stable, non-modifiable trait factors (antecedent variables demographic
factors such as age, ethnicity/race, marital status, education, employment status), clinical history
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(stage of cancer at diagnosis, treatment history, hormone use, family history of breast cancer and
trait anxiety), social/behavioral history (drinking, smoking, exercise history) and the outcome
variable (fear of breast cancer recurrence). Additionally, the study explored the relationship
between modifiable state factors (mediator variable such as state anxiety, depression, perceived
stress, pain, fatigue and sleep disturbances) considered to be transient and the outcome variable
fear of breast cancer recurrence. The antecedent trait factors associated with FOR and the
mediator state factors found to be most associated with fear of breast cancer recurrence were
studied by examining the potential mediating effects of those state factors on the trait factors
associated with fear of breast cancer recurrence. Understanding the relationship between trait
factors associated with fear of breast cancer recurrence that can be mediated by certain state
factors most associated with fear of recurrence can inform health care professionals to directly
target and prioritize interventions towards those women at risk for psychological distress during
survivorship.
Aims
The aims of this study were to:
1) Examine the relationship between the antecedent variables (non-modifiable (stable)
trait factors) including age, ethnicity/race, marital status, education, employment status, stage of
cancer at diagnosis, treatment history, history of smoking, drinking, exercise, hormone use,
family history of breast cancer and trait anxiety associated with the outcome variable, fear of
breast cancer recurrence (CARS overall fear and CARS nature of worry);
2) Examine the relationship between the mediator variables (modifiable (transient) state
factors) including state anxiety, depression, perceived stress, pain, fatigue and sleep disturbances
associated with the outcome variable, fear of breast cancer recurrence;
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3) Examine those state factors that mediate the relationship between trait factors
(antecedent variables) associated with fear of breast cancer recurrence (outcome variable).
Definition of Terms
The antecedent, mediator and outcome variables used in this study are outlined and defined
specifically in this section. For the purposes of this study, the following definitions were used:
1. Non-modifiable trait factors (antecedent variables): Those trait characteristics that cannot
be modified or are not easily modifiable and are stable over time including (age,
ethnicity/race, marital status, education, employment status, stage of cancer at diagnosis,
treatment history, history of smoking, drinking, exercise, hormone use, family history of
breast cancer and trait anxiety).
a. Trait anxiety: Defined as the general tendency to respond to perceived threats
with anxiety (Spielberger, Gorsuch, & Luschene, 1983).
2. Modifiable state factors (mediator variables): Those physiological states (pain, fatigue,
sleep disturbances) and psychological states (depression, perceived stress, state anxiety)
that is transient and may be modified through interventions. State is defined as a mode,
condition or stage in the physical being of something (Merriam-Webster, 2012).
a. Pain: Defined as an unpleasant subjective sensory and emotional experience
associated with actual or potential tissue damage (International Association for
the Study of Pain, 2013).
b. Fatigue: Defined as “a subjective state of overwhelming and sustained exhaustion
with a decrease in capacity for physical and mental work not relieved with rest”
(Cella, Peterman, Passik, Jacobsen & Breitbart, 1998, p. 369).
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c. Sleep disturbances: Difficulty falling asleep, staying asleep, waking up too early,
in ability to resume sleep or sleep that is non-restorative or poor in quality with
sleepiness during the day (Berger, 2009).
d. Depression: Subjective or observed depressed mood, feelings of guilt,
worthlessness, hopelessness, helplessness, change in appetite, sleep disturbances,
fatigue or loss of energy (Radloff, 1977).
e. Perceived stress: The situations in one’s life that are appraised as stressful
(Cohen, Kamarck & Mermelstein, 1983).
f. State anxiety: The temporary emotional state that is characterized by conscious
feelings of tension and apprehension and heightened autonomic system activity
(Spielberger et al., 1983).
3. Fear of breast cancer recurrence: Defined as fear that the breast cancer is coming back in
the same breast or another area of the body, or a new breast cancer (Vickberg, 2003,
p.18). The literature tends to use worry synonymously with fear in fear of recurrence
(Vickberg, 2003).
Delimitations
The sample included women who were post-treatment for breast cancer and included the
following parameters:
1. Ages 21 or older
2. Diagnosed with breast cancer Stage 0, I, II, III and had undergone; lumpectomy and
received adjuvant radiation and/or chemotherapy and were within 18 months post
treatment;
3. Able to read and speak English at an 8th grade level.
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Assumptions
The assumptions of this study support the concept that there are multiple factors
independently associated with higher levels of fear of breast cancer recurrence and several
factors that mediate the effects of fear of breast cancer recurrence. Some of the factors that may
be associated include age at time of diagnosis, stage of cancer at diagnosis, level of education,
history of anxiety, depression and perceived stress.
Significance of the Study
The management of breast cancer does not end with the diagnosis and treatment of the
disease and fear of breast cancer recurrence remains a persistent threat to cancer survivors. Many
studies have explored various influences on fear of cancer recurrence in breast cancer survivors
including demographic predictors, triggers, and emotional stressors (Gil et al., 2004; Lee-Jones,
et al., 1997; Lengacher et al., 2009; Lengacher et al., 2011; Mast, 1998; Mishel et al., 2005; Van
den Beuken-van Everdigen et al., 2008; Vickberg, 2003). However, the existing research has not
explored the mediating effects of modifiable state factors such as physical and psychological
factors on stable, non-modifiable factors like age, education, stage of cancer, treatment, etc. and
outcome of fear of cancer recurrence. Understanding these relationships provides valuable
information as health care providers attempt to individually tailor support and psychological
interventions early in breast cancer treatment and survivorship, thus reducing unnecessary
distress and promoting psychological health and well-being in breast cancer survivors. This
study establishes a uniqueness of examining the mediating effects of transient, modifiable state
factors on the relationship between stable, non-modifiable factors and fear of breast cancer
recurrence that goes beyond the existing published research.
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Chapter Two
Literature Review
Introduction
This chapter describes the theoretical model and framework and the empirical review of
the literature. The theoretical framework provides the model guided the empirical review of the
literature for the current research study. The review of the literature focused on the prevalence
of fear of recurrence in breast cancer survivorship and the main factors associated with fear of
recurrence including specific demographic, clinical, social/behavioral, physiological and
psychological concerns; this was followed by a summary of the findings.
Theoretical Framework
The theoretical framework guiding this study was the Theoretical Logic Model for
psychosocial nursing research (Evans, 1992). This model was used as a heuristic framework to
examine the associations between trait factors and state factors and the mediating effects on fear
of breast cancer recurrence. The logic model was designed to examine specific domains of
interest, studying specific variables and hypothesized relationships among the variables or
domains and the expected client outcomes (Evans, 1992). The model provided a sound
framework for this study that supports the examination and identification of factors strongly
associated with fear of breast cancer recurrence among breast cancer survivors.
Hypothesized Logic Model
The Logic Model for psychosocial nursing research was adapted for this study (Evans,
1992). The inputs of the model are comprised of the study subject’s baseline stable, non-
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modifiable trait factors including demographic factors (age, race/ethnicity, education, marital
status, employment), clinical history factors (stage of cancer at diagnosis, treatment type,
hormone use, family history of breast cancer, history of trait anxiety) and social/behavioral
history (exercise history, smoking and alcohol history).
The proposed model explores three pathways as depicted in Figure 1. The first pathway
evaluates the relationship between the antecedent variables (non-modifiable trait factors) and
outcome variable, fear of breast cancer recurrence (CARS overall fear and CARS nature of
worry). The second pathway evaluates the relationship between the mediator variables
(modifiable state factors) and the outcome variable, fear of recurrence (CARS overall fear and
CARS nature of worry). The antecedent and mediator variables strongly associated with fear of
cancer recurrence comprise the third pathway, the model for mediation. The mediation model
explains how mediating variables (modifiable state factors) influence the relationship between
the antecedent variables (non-modifiable trait factors) and the outcome variable, fear of
recurrence.
Review of Empirical Literature
The review of empiric literature for this study has been organized into several sections
including: 1) non-modifiable trait factors associated with fear of breast cancer recurrence such as
demographic factors (age, race/ethnicity, education, marital status, employment status), clinical
factors (stage of cancer at diagnosis, treatment history, hormone use, family history of breast
cancer, trait anxiety) and social/behavioral factors (exercise, smoking, alcohol use); 2)
modifiable state factors such as physiologic factors (pain, fatigue, sleep disturbances) and
psychological factors (depression, perceived stress, state anxiety), and 3) outcome variable fear
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of recurrence (CARS overall fear and CARS nature of worry). Many of the variables related to
fear of recurrence and breast cancer survivorship tend to be studied together as there tends to be
some overlap or clustering of some of the symptoms associated with fear of recurrence therefore
this review was organized into the categories most commonly studied in the literature.
Figure 1. Biobehavioral Logic Model

Note: Trait factors are defined as non-modifiable factors that are stable over time and state
factors are defined as modifiable (transient) factors that may be changed with interventions.

Demographic/Clinical Factors – Age, Stage, Education, Treatment and Fear of
Recurrence in Breast Cancer Survivors. The research highlights several demographic factors
13

associated with fear of recurrence in breast cancer survivorship. The two most common
demographic factors associated with fear of breast cancer recurrence in survivors are age and
level of education.
A quantitative study by Kornblith et al., (2007) of 252 breast and endometrial cancer
survivors in Boston, Massachusetts explored differences in adjustment between younger and
older survivors. Using the Fear of Recurrence Scale findings confirmed that younger (< 55
years) breast cancer survivors experienced higher FOR (p<0.0001) than older breast cancer
survivors (> 65 years) at baseline and for all cancer survivors younger survivors had higher FOR
after 1-year than the older women (p < 0.01) (Kornblith et al., 2007). It was also noted that
breast cancer survivors displayed significantly higher FOR than the endometrial cancer survivors
regardless of their age (p<0.0001) (Kornblith et al., 2007).
The interaction of threat appraisal and coping appraisal related to fear of recurrence was
studied in a cross-sectional sample of 155 early stage breast cancer patients post-treatment
(McGinty, Goldenberg & Jacobsen, 2010). Fear of recurrence was measured using the modified
Cancer Worry Scale (mCWS). Younger age (r = -0.25, p < 0.01) and more advanced disease
stage were the only variables that were significantly related to fear of recurrence (McGinty et al.,
2010). The interaction of age, disease stage, vulnerability and coping appraisal accounted for
34% of the variance (p <0.001) (McGinty et al., 2010). Threat appraisal accounted for 30% of
variance in fear of recurrence (p<0.001) and coping did not account for fear of recurrence, 0%
(p=0.64) (McGinty et al., 2010). However, those patients who reported high threat appraisal and
low coping appraisal interaction experienced the highest levels of fear of recurrence (p = 0.04)
(McGinty et al., 2010). Women who reported high perceived vulnerability and low coping
appraisal had the highest fear of recurrence (p < 0.02) (McGinty et al., 2010).
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A 2006 study of women’s personal concerns in breast cancer survivorship was performed
in a convenience sample of 35 Australian women age 40 years and younger that were within 4
years of their breast cancer diagnosis (Connell et al., 2006). The findings from this exploratory
study using semi-structured interviews revealed that for younger women (20 – 40 years of age)
showed fear of the future and cancer recurrence was the most common personal concern (54%)
and the top-ranking perceived concern (31.5%) (Connell et al., 2006). Twice as many the
women who had a lumpectomy reported fear of recurrence as their major personal concern
compared to those survivors that had a mastectomy (Connell et al., 2006).
A study of 2290 women with non-metastatic breast cancer in Detroit and Los Angeles
examined worry about recurrence related to race/ethnicity and health care experiences (Janz et
al., 2011). In the design of this study Latina and African Americans were oversampled (Janz et
al., 2011). Using a worry scale created by the researcher, findings revealed that low acculturated
Latinas reported more worry than African Americans and Whites and African Americans
reported significantly less worry than whites (p < 0.001) (Janz et al., 2011). Women who were
younger age, Latina, employed, married and less educated experienced greater worry (Janz et al.,
2011). Persistent pain and fatigue and higher cancer stage during treatment indicated greater
worry (Ps <0.05) (Janz et al., 2011). Patient who had a lumpectomy, radiation and/or
chemotherapy reported more worry compared to those that had a mastectomy (Ps<0.05) (Janz et
al., 2011).
A qualitative study of 18 Australian women post treatment (6-24 months) for early stage
breast cancer was performed using telephone interviews (Thewes, Butow & Pendlebury, 2004).
Pain and fatigue were reported most commonly as late effects of their treatment in the younger
and older women (Thewes et al., 2004). The women also reported the need to be assured that
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their symptoms were normal and reassurance that it was not recurrence of their cancer (Thewes
et al., 2004). Many of the women reported fears physical symptoms would indicate that the
cancer would return (Thewes et al., 2004). Although most of the fears of recurrence did not
impact quality of life, some of the younger women related their fears to the limited ability to plan
for the future or to have children (Thewes et al., 2004). It is important to note that some of the
younger women reported that the information they received during and after treatment as not
completely relevant to their needs, nor were the support groups relevant to the younger age
(Thewes et al., 2004). Additionally they requested more information about complimentary
therapies, diet, exercise and healthy living than the older women (Thewes et al., 2004).
A prospective, descriptive study of 291 Australian breast cancer survivors was performed
to examine characteristics associated with cancer treatments and impact on quality of life (King,
Kenny, Hall, & Boyages, 2000). Findings revealed that older women had better body image (p<
0.0001), social and emotional functioning (p< 0.0001), experienced less pain (p< 0.00047) and
fear of cancer recurrence (p < 0.0001) than younger women (King et al., 2000). Additionally,
who more educated (vocational/tertiary education) reported less physical symptoms (p= 0.0001
and p=0.0057), pain (p=0.0057) and better emotional (p=0.015) and physical (p=0.021)
functioning than those breast cancer survivors with only secondary school education (King et al.,
2000). In general quality of life dimensions for the younger women was less than their older
counterparts (King et al., 2000).
Australian women (N =218) ages 18-45 diagnosed with stage 0-2 breast cancer within 1year of diagnosis participated in a study examining women’s fears of breast cancer recurrence
(Thewes et al., 2012). Using the Fear of Cancer Recurrence Inventory (FCRI), the researchers
found associations between fear of cancer recurrence and frequency of self-breast exams,
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doctor’s visits and complementary and alternative medicines (CAM). Age at diagnosis was the
only confounder associated with fear of cancer recurrence that was adjusted for and was found to
be statistically significant (Thewes et al., 2012). The total FCRI decreased by 1.3 for each
additional year of age with a (95% CI -2.0, -6.9; p < 0.0001) (Thewes et al., 2012). High fear of
cancer recurrence has been associated with more unscheduled visits to the doctor, higher
frequency of breast screening and cancer screening, counseling and support groups (Thewes et
al., 2012). In the same study women who had higher levels of fear of recurrence also used more
CAM and spent more money on CAM (Thewes et al., 2012). Higher fear of recurrence was also
associated with not having mammograms, ultrasounds or other cancer screening exams unlike
those that reported receiving an ultrasound or mammogram in the past year experienced lower
levels of fear of recurrence (Thewes et al., 2012). This study found that between 64% and 76%
of young women with a history of early breast cancer reported clinical levels of fear of cancer
recurrence demonstrating that younger women diagnosed with breast cancer are at greater risk
for experiencing greater fear of cancer recurrence (Thewes et al., 2012).
A study of the efficacy of senior peer counseling by telephone for supplemental
psychosocial support in a sample of 142 California women ages 50-94 that were newly
diagnosed with breast cancer stage 0-3 was done in 2012 by Crane-Okada et al. Using the Fear
of Recurrence (FOR) scale by Northouse (1981) findings revealed that there was a significant
main effect of age and fear of recurrence and community resource utilization (Crane-Okada et
al., 2012). Younger women reported a higher ( = 75.7, SD = 16.4) of fear of recurrence with a
higher number of community resources used ( = 3.1, SD = 1.5) than the older women’s fear of
cancer recurrence ( = 67.5, SD = 15.6) and resources used ( = 2.4, SD = 1.7) (Crane-Okada et
al., 2012). Another main effect at baseline that was significant was age; younger patients (aged
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50-64 years) used coping by seeking support more than their older counterparts (Crane-Okada et
al., 2012). This was consistent at six months among the younger patients who were more likely
to use coping strategies than the older participants (Crane-Okada et al., 2012). At each time
point during the study fear of recurrence was highest for those patients who were alone and
anxious at baseline suggesting this group would be most in need of therapeutic interventions
(Crane-Okada et al., 2012).
A study of 714 breast cancer survivors who underwent breast-conserving therapy at the
University of Michigan, Ann Arbor, Michigan found that approximately 27% of the women
experienced high levels of fear of recurrence and 22% reported depressive symptoms (Waljee et
al., 2008). Younger women (< 40 years) reported feeling stigmatized from the treatment they
received for their breast cancer (Waljee et al., 2008). Fear of recurrence was higher in women
with pronounced breast asymmetry post breast cancer treatment opposed to women who
experienced minimal and moderate asymmetry (pronounced asymmetry, 40.4%; minimal
asymmetry, 19.8%; moderate asymmetry, 19.0%; Wald test = 21.5; p < 0.001) (Waljee et al.,
2008). Patient age was also significantly related to fear of loss of health (p < .001) and disease
stage was significantly associated with fear (p = 0.05) (Waljee et al., 2008).
An Australian qualitative study using a focus group methodology explored the current
needs and concerns of 10 women who recently completed treatment for breast cancer (Oxlad,
Wade, Hallsworth & Koczwara, 2008). One of the themes revealed in the study was fear of
breast cancer recurrence immediately following primary treatment completion. This concern
consisted of specific thoughts about whether the treatment they were receiving was keeping the
cancer away, if the cancer would return, how long they would have to live and what would
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happen when the treatment (primary and secondary) stopped causing fears about recurrence
(Oxlad et al., 2008).
In a descriptive exploratory study using telephone interviews with a convenience sample
of 200 breast cancer patients from Illinois found that 39% of the patients reported fear of breast
cancer recurrence, including concerns that the cancer had traveled to other parts of the body,
concerns about the success of their surgery and that the cancer might return (Stephens et al.,
2008). In general, Stephens et al. (2008) found that fear of recurrence was a real threat for
patient’s receiving any breast cancer surgery leaving concerns about the success of the surgery
and the fear of recurrence 1-week post-operative for breast cancer surgery (Stephens et al.,
2008).
A cross sectional, descriptive study of 109 women post-treatment for breast cancer in the
southeastern United States participated in examining the variables associated with illness
uncertainty and emotional distress in survivorship (Mast, 1998). Several main findings were
identified, first age was inversely related to fear of cancer recurrence (older women were less
likely fear cancer uncertainty than younger women) (p<0.01) and women with four or more
years of college had lower illness uncertainty than women with less than two years of college
(p=0.008) (Mast, 1998). Secondly, symptom distress (those symptoms residual from cancer
treatment or new unknown symptoms) and fear of cancer recurrence contributed to greater
emotional distress (p= 0.003) (Mast, 1998).
In summary, the younger breast cancer survivors tend to experience greater levels of fear
of cancer recurrence than their older survivors (Connell et al., 2006; Crane-Okada et al., 2012;
Janz et al., 2011; King et al., 2000; Kornblith et al., 2007; Mast, 1998; McGinty et al., 2010;
Thewes et al., 2012; Waljee et al., 2008). In several studies women who were less educated

19

reported greater FOR than those with some college education (Janz et al., 2011; King et al.,
2000; Mast, 1998) and one study found that low acculturated Latinas experienced increased FOR
than African American survivors (Janz et al., 2011). In some of the studies increased fear of
cancer recurrence was associated with the increased stage of the cancer at diagnosis (McGinty et
al., 2010; Waljee et al., 2008). Treatment concerns were associated with FOR regarding type of
treatment, esthetics of breasts after treatment and effectiveness of treatment. FOR was increased
in those patients who had lumpectomy compared to mastectomy patients (Connell et al., 2006;
Janz et al., 2011), more breast asymmetry post treatment (Waljee et al., 2008) and worries about
the treatment being effective enough to keep the cancer away (Oxlad et al., 2008; Stephens et al.,
2008).
Pain, Fatigue, Sleep Disturbances and Fear of Breast Cancer Recurrence.
Modifiable state factors associated with fear of breast cancer recurrence include physiological
symptoms such as pain, fatigue and sleep disturbances and psychological factors including
depression, perceived stress and anxiety.
A qualitative study in 2007 studying 20 breast cancer survivors in the northeastern United
States their physical, psychological needs and associated information and support needs during
survivorship (Cappiello, Cunningham, Knobf, & Erdos, 2007). The results found that the women
in this sample reported fatigue as the greatest physical complaint across all three-time periods (3,
6 and 12 months) and that the fatigue “never stopped” even after treatment (Cappiello et al.,
2007, p. 283). Sleep difficulties were also ranked high among the physical symptoms, frequently
citing fear of cancer recurrence as a cause for sleep disturbances (Cappiello et al., 2007). The
main psychological complaint was fear of recurrence that persisted through the first year posttreatment causing increased anxiety (Cappiello et al., 2007). Overall, anxiety was also a common
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concern during the first year, however changes in mood and sadness dissipated over time
(Cappiello et al., 2007). Women reported that one of their greatest challenges was “trying to get
back to normal” after treatment for breast cancer and that they could have benefited from more
information during the transition (Cappiello et al., 2007, p. 287). These findings indicate the
need for further information and support for women acclimating from treatment to routine living
during the first year post breast cancer treatment (Cappiello et al., 2007).
A descriptive analysis of 203 Caucasian and African American breast cancer survivors 59 years post-treatment were studied to assess the influence of symptoms, uncertainty and
communication with providers on well-being (Clayton, Mishel, & Belyea, 2006). Results
yielded that symptom bother (pain, fatigue and other symptoms) accounting for 11% of the
variance related to thoughts of cancer recurrence (Clayton et al., 2006). Age was found to be
directly associated with symptom bother (as age increased symptom bother decreased) and
indirectly associated with feelings of decreased uncertainty, better mood and lower worry of
recurrence (Clayton et al., 2006).
A study of 572 breast cancer survivors in the Western United States investigated patterns
of sleep duration change across the breast cancer survivorship period including demographic and
clinical predictors and cancer-related symptoms (Alfano et al., 2011). Findings revealed that half
of the survivors did not report sleep changes over time however 25% reported sleep changes that
were temporary, late-occurring or a sustained change (Alfano et al., 2011). Those survivors with
the sustained or temporary change were more likely to have been treated with chemotherapy
(p<0.001) or experienced weight gain post diagnosis (p=0.04) (Alfano et al., 2011). The group
who experienced sustained sleep change reported greater fatigue related concerns (severity,
affective, and sensory) (p<0.0001) compared to the no change group (Alfano et al., 2011). There
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were no significant findings between the sleep groups with regard to fatigue, fear of recurrence
or perceived stress (Alfano et al., 2011). Their findings suggest that survivors treated with
chemotherapy and those with weight gain post breast cancer diagnosis may be at greater risk for
sleep pattern changes hence greater risk for fatigue implicating the need for sleep screening and
intervention as part of routine cancer survivorship assessment (Alfano et al., 2011).
Triggers of uncertainty regarding breast cancer recurrence were studied in 244 Caucasian
and African-American women 5 to 9 years post-breast cancer diagnosis (Gil et al., 2004). The
women in this study reported an average of 2 triggers of uncertainty per month consisting of
hearing about someone else having cancer, doctor’s appointments, and cancer information in the
media (news, TV) (Gil et al., 2004). Other triggers included new aches, pains or other physical
symptoms, and sights, sounds and smells that reminded them of their breast cancer experience;
although their fear of recurrence was not constant the triggers remained persistent over time (Gil
et al., 2004). The most common trigger for African-American women was new symptoms and
for Caucasian women hearing about someone else with cancer (Gil et al., 2004). Older women
reported significantly fewer triggers (r = -0.16, p<0.01) and women with higher education
reported more triggers (r=0.21, p<0.001) (Gil et al., 2004). Caucasian women were more likely
to report their fear of recurrence being triggered by hearing about someone else’s cancer,
environmental factors and information in the media regarding cancer than African-American
women (Gil et al., 2004).
An exploratory qualitative analysis of 276 email messages from 60 breast and prostate
cancer patients in Norway examined the content of emails sent to oncology nurses (Grimsbo,
Finset, & Ruland, 2011). Themes from the 38 breast cancer patients revealed that women
expressed fear and anxiety related to relapse or metastases. Their fear was related to physical
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changes in their bodies (new experience of pain in their breasts or armpits and tiredness)
(Grimsbo et al., 2011). Expressing concerns about every little change in the body, topics they
read about in the paper related to cancer and knowing about patients that receive other types of
treatment (Grimsbo et al., 2011). A final trigger that was identified was related to topics that
patients read about in the newspaper and in their peer-to-peer on-line communication involving
the type of cancer treatment they received in comparison to their peers raising concerns about
their choices and effectiveness of the treatment they received (Grimsbo et al., 2011).
A cross-sectional study in Italy examined quality of life, fatigue and depression in 255
long-term breast cancer survivors (Romita, Cormio, Giotta, Colucci & Mattioli, 2012). The
mean survival time was 10.5 years (range 5 to 32 years), education level was low with less than 8
years of school, most had received combined therapy (surgery, radiation and chemotherapy), the
majority did not smoke and also did not exercise (Romita et al., 2012). Sleep patterns in this
sample reported regular sleep (50%) and 46% reported disturbed sleep (Romita et al., 2012).
Survivors with lower education (p=0.007) and two or more comorbidities experienced greater
fatigue, fatigued survivors were significantly more depressed (p=0.000) and reported more
disrupted sleep (p=0.000) overall fatigue was found to be moderate and severe (34%) and mild
(66%) (Romita et al., 2012). These findings were similar with depression, survivors with
depression (37% depressed, 20% moderate to severe depression) were found to have higher
fatigue (p=0.000) and more disturbed sleep (p=0.000) (Romita et al., 2012).
A study of 47 breast cancer survivors within 1 to 14 months post treatment found that the
majority of the women experienced persistent and troubling fears about disease recurrence
(Allen, Savadatti, & Levy, 2009). These fears were often triggered by physical symptoms of
unknown origin, and that sometimes they described their distress or depression as being related
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to fear of recurrence (Allen et al., 2009). Fear of recurrence was common and persistent,
although women transitioning out of treatment who exhibited fear and distress were also
identified as very resilient (Allen et al., 2009). With these findings the researchers recommend
that there are implications for nursing and other healthcare providers to consider the transition
period post treatment as “window of opportunity” to support women’s coping mechanisms and
strategies to promote health and well-being (Allen et al., 2009, p.76).
A qualitative study of semi-structured interviews with sixteen women post- breast cancer
treatment examined the nature of thoughts and feelings regarding the possibility of breast cancer
recurrence (Vickberg, 2001). Findings revealed that five of the sixteen women experienced
strong feelings of recurrence whereas five other women expressed little or no fear of recurrence
one citing that she felt blessed and confident that the cancer was not going to come back
(Vickberg, 2001). In addition, triggers associated with fear of recurrence were examined with
being around others with cancer or hearing about cancer being the most common trigger of fear
of recurrence (Vickberg, 2001). Doctor appointments and testing such as mammograms and
future oriented activities also created anxiety associated with fears of recurrence (Vickberg,
2001). Three of the women expressed that fear of recurrence was triggered by physical
symptoms from the initial breast cancer (Vickberg, 2001).
In summary, physical symptoms such as pain, fatigue, anxiety and symptoms related to
the cancer treatment were found to be associated with increased FOR (Allen et al., 2009; Clayton
et al., 2006; Gil et al., 2004; Grimsbo et al., 2011; Vickberg, 2001). Older women reported
reduced symptom bother or triggers and lower worry of cancer recurrence (Clayton et al., 2006;
Gil et al., 2004). Those women with less education reported greater fatigue and fatigued
survivors were more depressed and had more disturbed sleep (Romita et al., 2012) and FOR was
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reported as the cause for sleep disturbances in some women and was cited to be their main
psychological complaint that persisted throughout the first year post treatment creating increased
anxiety (Cappiello et al., 2007).
Depression, Perceived Stress and Anxiety and Fear of Breast Cancer Recurrence.
Depression, perceived stress and anxiety and their association with fear of breast cancer
recurrence has become a greater concern in the study of breast cancer survivorship in terms of
improving quality of life through early screening and intervention. A study of 89 women
examined depression, anxiety and cancer related distress post-treatment for breast cancer
(Costanzo et al, 2007). They found depression, anxiety and cancer related distress to be true for
younger women and those women of any age with some history of college education
demonstrated greater distress (Costanzo et al, 2007). Women demonstrated elevated depression
with a self-reported history of anxiety, depression or emotional disturbance and also those taking
antidepressants were at greater risk for depressive symptoms (Costanzo et al, 2007). Women
who received more extensive treatment had greater cancer-related anxiety but not depressive
symptoms and those women who received chemotherapy had a greater recurrence worry than
those who only received radiation (Costanzo et al, 2007). Stage of cancer was not found to be
significant (Costanzo et al, 2007).
Factors contributing to adaptive survivorship were examined in a longitudinal study of 70
women with Stage I and II breast cancer in the Midwest, United States (Stanton et al., 2002).
Using the Fear of Recurrence Scale by Northouse the researchers found that older women
reported less fear of recurrence at 3-months (r=-0.39, p<0.001 and 1-year (r = -0.52, p<0.001)
(Stanton et al., 2002). Avoidance-oriented coping at study entry was related to lower Profile of
Mood States Distress at 3-months but increased fear of recurrence at 1 year (Stanton et al.,
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2002). At 1 year, older women reported less fear of recurrence (partial r = -0.29, p < 0.05)
(Stanton et al., 2002). Women who scored high in hope were predicted to have lower fear of
cancer recurrence 3-months later if they coped through positive reinterpretation at diagnosis
(p<0.05) (Stanton et al., 2002). Coping through avoidance at diagnosis predicted decreased fear
of recurrence distress at 3-months but higher fear of recurrence at 1-year for 70 women with
stage I and II breast cancer through their first year of treatment; this finding suggests that
avoidance is an important risk factor for cancer specific maladjustment (Stanton et al., 2002).
Post-menopausal women (N=153) in New Zealand with early stage breast cancer
participated in a cross-sectional study design to examine the relationship between fear of
recurrence and illness perceptions, medication beliefs, treatment side effects, demographic
factors and emotional distress (Corter, Findlay, Broom, Porter & Petrie, 2013). Using the Worry
About Cancer scale to measure fear of recurrence a significant difference was seen in fear of
recurrence between unemployed women (M=15.1, SD = 8.6) and employed women (M=12.9,
SD=6.2) (p=.03) with unemployed women experiencing greater fear of recurrence (Corter et al.,
2013). No differences were noted between younger and older women (p=.12), in a relationship or
not in a relationship (p=.95), ethnicity (p=.27) or time since diagnosis (p=.07) (Corter et al.,
2013). There were no noted differences between women who received chemotherapy and those
that did not and those that had radiation and those that did not (Corter et al., 2013). There was
significant relationship between mean anxiety and depression scores and fear of recurrence (p
=0.001) (Corter et al., 2013). Higher fear of recurrence was associated with more symptoms
related to breast cancer (p=0.001) and those that believed that their cancer was caused by stress
experienced significantly higher fear of recurrence (p=.05) than women who did not know what
caused their cancer (p= .01), lifestyle, hormones, genetics and chance were not significantly
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related to fear of cancer recurrence (Corter et al., 2013). In the regression model, fear of
recurrence was significantly associated with negative emotions including lower beliefs about
treatment control (p=0.001), greater timelines of experiencing breast cancer (p=0.002) and more
symptoms associated with breast cancer (p<0.05) (Corter et al., 2013). Illness perceptions,
beliefs about medicines, number and severity of reported side effects from aromatase inhibitors,
anxiety, depression and employment status comprise about 61% of the variance in fear of
recurrence scores (Corter et al., 2013).
A study of 307 women in the Netherlands with early stage breast cancer (n=117) or
benign breast problems (n=190) looking at social, psychological, support factors and predictors
of fatigue at 6 and 12 months post-surgical treatment (De Vries, Van der Steeg & Roukema,
2009). In the breast cancer group predictors of fatigue were depressive symptoms, poor social
support and neuroticism (De Vries et al., 2009). In the breast cancer group, none of the
demographic or clinical factors predicted fatigue at Time 2 and 3 (De Vries et al., 2009). Trait
anxiety (p < 0.001) and extraversion (p < 0.05) at Time 2 and trait anxiety (p<0.05), extraversion
(p<0.05), and depressive symptoms (p<0.05) at Time 3 predicted fatigue in the breast cancer
group (De Vries et al., 2009). These findings suggest that those individuals that are fatigued
early in their diagnosis many will continue to experience fatigue later on in their treatment and
post-treatment therefore suggesting early fatigue screening and intervention (De Vries et al.,
2009).
In a study of 331 ethnically diverse women in California within 3 to 7 months of
diagnosis were examined for depressive symptoms (Wong-Kim & Bloom, 2005). Younger
women with higher levels of pain (p = 0.035), lower levels of self-esteem (p < 0.0005) and lower
emotional support (p < 0.0005) were at greatest risk for depressive symptoms (Wong-Kim &
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Bloom, 2005). However women of any age with severe treatment side effects, low self-esteem
and low emotional support were also at risk (Wong-Kim & Bloom, 2005). Only amount of pain
predicted depressive symptoms; conversely disease severity, type of surgery, number of positive
lymph nodes, nausea were not significant for predicting depressive symptoms (Wong-Kim &
Bloom, 2005).
A prospective quality of life study of 506 women diagnosed with ductal carcinoma in situ
(DCIS) or early invasive breast cancer (EIBC) stage I – IIA was performed using interviews at 46 weeks, 6 months and 2 years post-treatment (Liu et al., 2011). Moderate fear of recurrence
was reported in 24.8% of patients and 4% of the women reported high levels of fear of
recurrence (Liu et al., 2011). Using three stepwise multivariable linear regression models Liu et
al., (2011) found that younger age, EIBC stage IIA breast cancer, lower social support and
elevated anxiety was associated with higher fear of cancer recurrence (measured with 4-items
from the Concerns About Recurrence Scale (CARS) (P < 0.05; final models R² = 0.25-0.32).
DCIS patients had lower FOR than stage IIA patients (P < 0.01) (Liu et al., 2011). Breast cancer
survivors with higher levels of education (> high school) reported less FOR at baseline and
greater depressive symptoms at baseline had higher fear of cancer recurrence; neither of these
symptoms were observed at 6-months or 2-years (Liu et al., 2011).
A study of 1,957 breast cancer survivors in California examined the occurrence of fatigue
and associated demographic, medical and psychological factors compared to the general
population (Bower et al., 2000). Women who were who were fatigued were younger (p < 0.05),
earned lower annual income (p < 0.05) and less likely to be in a significant relationship (p <
0.05) (Bower et al., 2000). Women in the fatigue group also experienced more physical
complaints such as arthritis (p < 0.05), headaches (p < 0.05) and heart disease (p < 0.05) (Bower
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et al., 2000). The women in the fatigue group were also more likely to have been treated with
chemotherapy or chemotherapy and radiation than their non-fatigued counterparts (Bower et al.,
2000). Women with fatigue reported greater sleep disturbances, more severe and disabling pain
and higher level of depressive symptoms (Bower et al., 2000). The greatest predictors of fatigue
were depression (p = 0.0001) and pain (p = 0.0001) (Bower et al., 2000). Although fatigue was
not a significant concern for the women in this study, those women that did experience fatigue
were more likely to experience depression, bodily pain and sleep disturbances (Bower et al.,
2000).
A study of 169 women (81 with breast cancer and 88 benign breast problems) in The
Netherlands found that trait anxiety assessed before diagnosis was the only significant predictor
of depressive symptoms (r = .59, p < 0.001 before diagnosis and r = .66, p < 0.05 at 1-month)
and fatigue (r = .66, p < 0.001 before diagnosis and r = .60, p < 0.001 at 1-month) (De Vries,
Van der Steeg, & Roukema, 2009). Age, marital status, having children and having paid work
were unrelated to trait anxiety, depressive symptoms or fatigue (DeVries et al., 2009). Patients
with benign and breast cancer with high trait anxiety also scored high on fatigue (DeVries et al.,
2009). The results identified that by incorporating all four time points (pre-diagnosis, 1-month,
3-months, 6-months) among both groups (benign and breast cancer) that patients who scored
high on trait anxiety appeared to be at risk for developing depressive symptoms and fatigue
(DeVries et al., 2009). The researchers recommend that women with a suspicion of breast cancer
should be screened for trait anxiety and for those individuals who score high in trait anxiety
psychological therapy should be offered as part of their treatment plan (DeVries et al., 2009).
A study in Scotland examined the prevalence of severe fatigue and associations with
activity level and psychological distress in 69 breast cancer survivors at least 6-months post-
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treatment (Young & White, 2006). Those patients that experienced cancer related fatigue also
reported greater symptoms of anxiety, depression and psychological distress (p<0.001) (Young
& White, 2006). Fatigue increased as the number of treatment modalities increased for those
survivors with fatigue (p<0.05) (Young & White, 2006). Correlations were significant between
fatigue and beliefs about activity, psychological distress, and fear of recurrence (p<0.01). Fear
of recurrence was found to be a significant predictor of fatigue but was mediated by
psychological distress and beliefs about activity and therefore fear of recurrence had an indirect
association with fatigue (p< 0.01) (Young & White, 2006).
A recent cross-sectional study of 1,128 long-term breast cancer survivors in two
Midwestern university cancer centers explored the effect of age at diagnosis on fear of breast
cancer recurrence and predictors of fear of recurrence (Ziner et al., 2012). Younger women were
defined as ages 45 years and younger and older age was considered 55 to 70 years of age (the
age gap from 46 – 54 years was deliberate as part of the study design) (Ziner et al., 2012).
Findings were based the 505 younger women and 623 older women who participated in the
study. Consistent with the literature the younger women experienced greater fear of recurrence
than the older women in the study (t = 7.7 – 15.4, p < 0.001) (Ziner et al., 2012). Age (p =
0.001), perceived risk of recurrence (p = 0.001, trait anxiety (p = 0.001) and breast cancer
reminders (p = 0.001) were all associated with fear of recurrence (Ziner et al., 2012). Although
age at diagnosis was not associated with breast cancer survivor self-efficacy (ability to manage
symptoms, emotions and facilitate support related to breast cancer) breast cancer survivor selfefficacy was inversely related to higher perceived risk of recurrence (p = 0.07), symptom bother
(p< 0.001), and trait anxiety (p < 0.001) (Ziner et al., 2012). Breast cancer survivor self-efficacy
predicted lower fear of cancer recurrence (r = -0.183, p < 0.001) and demonstrated a partial
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mediation effect (p = 0.05) on the relationship between the antecedent variables age at diagnosis,
perceived risk of recurrence, trait anxiety and breast cancer reminders and outcome variable fear
of recurrence (Ziner et al., 2012).
Understanding more about fear of recurrence and how the demographic, psychological
and physiologic factors influence fear of recurrence will shape the future interventions become
more individualized and targeted. The shift from breast cancer diagnosis and treatment to
quality of life and well-being related to the psychological needs during survivorship has brought
fear of breast cancer recurrence to the forefront as a priority for further investigation.
In summary, psychological symptoms associated with FOR were found to be
bidirectional in their relationships and associated with other demographic factors. Anxiety was
found in some of the studies to be associated with increased FOR (Corter et al., 2013; Liu et al.,
2011; Ziner et al., 2012) and depression (Corter et al., 2013). Trait anxiety predicted fatigue
(DeVries et al., 2009) and depressive symptoms (DeVries et al., 2009). Younger women with
higher levels of pain, women of any age with severe treatment side effects and both younger and
older women with low self-esteem and low social support were at greater risk for depressive
symptoms (Wong-Kim & Bloom, 2005). Younger age, lower social support, increased anxiety
and greater depressive symptoms at baseline was associated with increased FOR however
women with higher education reported less FOR at baseline (Liu et al., 2011). Increased cancer
related fatigue was associated with greater anxiety, depression, psychological distress and fear of
recurrence (Young & White, 2006).
Fear of Recurrence and Breast Cancer Survivors. The National Cancer Institute
(2013) defines cancer recurrence as a cancer that returns where it started or in another place in
the body after treatment and after a period of time that the cancer could not be detected. The
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literature tends to use worry and uncertainty synonymously with fear in fear of recurrence
(Simard & Savard, 2009; Vickberg, 2003) and hence the development of various fear of
recurrence instruments. In a 2009 study validating a fear of recurrence inventory, the author
argued that one of the challenges with researching fear of cancer recurrence was the lack of
consensus for an accepted definition for fear of recurrence (Simard & Savard, 2009). Despite
some of these differences fear of cancer recurrence has become a legitimate concern related to
breast cancer survivorship.
The Concerns About Recurrence Scale (CARS), an instrument developed by Vickberg
(2003), was designed to assess the overall fear and the extent and nature of women’s fears about
the possibility of breast cancer recurrence. The instrument was assessed in 169 breast cancer
survivors from five physician practices at a large New York City medical center. Participants
needed to be 18-years of age or older, speak English, within 7 years of diagnosis of local or
regional breast cancer and have received surgery for breast cancer and post-treatment (Vickberg,
2003). The CARS defines fear of recurrence as “the breast cancer coming back in the same
breast or other areas of the body or a new breast cancer on either breast” (Vickberg, 2003, p. 18).
The CARS contains two parts: 1) the overall fear of recurrence and 2) the nature of women’s
fears of recurrence (Vickberg, 2003).
Using exploratory factor analysis conducted to determine the structure of the CARS and
to identify meaningful subsets of items the results yielded a four-factor solution that accounted
for 70% of the variance (Vickberg, 2003). The overall fear index was found to have a high
internal consistency (α =.87) and significantly correlated with all four CARS subscales: Death (r
= .64); Health (r = .64); Roles, (r= .50), and Womanhood (r = .53) (all correlations p < .0001)
(Vickberg, 2003). Approximately 45% of the women reported moderate levels of fear of
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recurrence and 10% high levels of fear; for some of the women recurrence was the biggest fear,
aware that disease could recur at any time and others revealed that the fears were subtle yet
constant in addition to some revealing that fear of recurrence interfered with their ability to plan
for the future (Vickberg, 2003). Finally, the background variable of age was the only significant
variable found to be negatively related to overall fear (p < .05) (Vickberg, 2003). Vickberg
(2003) found that stage of cancer, mastectomy and time since diagnosis were not a predictor of
FOR.
A study of 72-breast cancer survivors was studied for severity of four common concerns
(fear of the future, physical limitations, pain, problems with family or friends) at 3, 7, 11, 15
months and 6 years after diagnosis (Lebel et al., 2007). They found that fear of the future (fear
of recurrence) was the most stressful concern for breast cancer survivors (Lebel et al., 2007).
They noted that although the perceived stressfulness of fear of the future appeared to decline
during the 3 and 7-month period after diagnosis, it stabilized at a constant state through 6 years
(Lebel et al., 2007).
A prospective Dutch study of 136 breast cancer survivors designed to evaluate the
psychometric properties of the Dutch version of the Concerns About Recurrence Scale (CARS)
and to measure the concerns about disease recurrence and how fear of recurrence effects quality
of life (Van den Beuken-van Everdingen et al., 2008). Moderate to high levels of fear were
reported by 56% of women with pain found to be a strong predictor of fear of recurrence
(p<0.001), overall fear decreased with age (p < 0.012) (Van den Beuken-van Everdingen et al.,
2008). Women with higher education levels had significantly more health and role worries (on
the CARS subscales) than women with lower education (Van den Beuken-van Everdingen et al.,
2008).
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In a German study or 1083 breast cancer survivors character and frequency of fear of
cancer progression was studied with the relationship with cancer-related intrusive cognitions
(Menhert, Berg, Henrich & Herschbach, 2009). Findings revealed significant correlations
between fear of cancer progression and intrusive thoughts (r=0.63), avoidance (r= 0.57),
hyperarousal (r=0.54) and posttraumatic stress disorder diagnosis (r=0.42) (Menhert et al., 2009).
Intrusive thoughts and being afraid of disease progression demonstrated the highest relationship
along with having physical symptoms of anxiety such as rapid heart rate, being afraid of severe
medical treatments and being nervous prior to doctor’s appointments (Menhert et al., 2009).
An exploratory study describing the extent and nature of fear of cancer recurrence in
relation to socio-demographic characteristics, treatment related characteristics, psychological
distress and quality of life in 51 African-American breast cancer survivors in Washington D.C.
was performed (Taylor et al., 2011). Sixty-seven percent of the women reported some degree of
fear of recurrence and low to moderate levels of fear of recurrence (M=2.65, SD=1.44) using the
Concerns About Recurrence Scale (CARS) (Taylor et al., 2011). Overall fear was negatively
associated with time since diagnosis (r =-.35, p < .05) and negatively related to quality of life
(r=-.38, p>.01) (Taylor et al., 2011). In addition, overall fear of recurrence was positively related
to global psychological distress (r = .43, p < .01), younger patients experienced higher levels of
fear of cancer recurrence and there was no difference between fear of cancer recurrence worries
and surgery type (Taylor et al., 2011).
A qualitative study of 21 breast cancer survivors at least 3-months post-treatment in
California exploring the different quality of life experiences and needs (Ferrell, Grant, Funk,
Otis-Green & Garcia, 1997). Some of the common shared experiences expressed by the women
related to physical well-being were pain, fatigue, insomnia and that their complaints were not
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always taken seriously by their health care team (Ferrell et al., 1997). Fear of recurrence was a
common shared experience for the women, and although it may dissipate for periods of time
throughout survivorship physical reminders of the cancer or hearing about cancer would recreate
fears of recurrence; one women stating “I guess it just never goes away” (Ferrell et al., 1997,
p.20). This early study provided a foundation for further exploration, support, management and
intervention of quality of life issues in breast cancer survivorship.
A study of 89 breast cancer patients from 5-Midwest treatment centers examined the
psychological adjustment during the 3-months following treatment for breast cancer and health
related quality of life (Costanzo et al., 2007). Many of these women experienced moderate
cancer related anxiety and concerns about ongoing physical symptoms and fear of cancer
recurrence using the Concerns About Recurrence Scale (CARS) (Costanzo et al., 2007). Level of
education (mainly some college but less than those who completed college or a graduate degree)
predicted greater FOR distress (p < 0.001) (Costanzo et al., 2007). Aside from side effects and
physical problems, fear of recurrence was the greatest source of distress during the post
treatment period (Costanzo et al., 2007). Women who reported extensive treatment therapy
(mastectomy) were found to be a greater predictor of fear of recurrence distress than women who
received lumpectomy (p =0.012) at 3-months in 71 breast cancer survivors (Costanzo et al.,
2007).
A study examining factors associated with quality of life in a sample of 246 randomly
selected cancer survivors and their family members was performed to identify factors associated
with fear of recurrence of cancer survivors and their caregivers and to determine if survivors and
family caregivers influenced each other’s fears of recurrence (Mellon, Kershaw, Northouse, &
Freeman-Gibb, 2007). Study findings identified that fear of recurrence was predominately
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determined by the individual not by their partner and that each person’s perception had more
influence on their individual level of fear of recurrence then the influence on their partner
(Mellon et al., 2007). One partner effect finding was that older survivors with younger
caregivers and older caregivers with younger partners both experienced increased fear of cancer
recurrence (p < 0.01) and caregivers who were family members also experienced greater fear of
recurrence (p < 0.001) (Mellon et al., 2007). Families that reported concurrent family stressors
had more fear of recurrence and the lower quality of life (p < 0.01) (Mellon et al., 2007).
Survivors and caregivers who had more positive meaning with the illness experienced
significantly less fear of recurrence (p < 0.01) (Mellon et al., 2007).
A study of 231 cancer survivors, including breast cancer survivors (n = 94), found fear of
recurrence to be a predictor for increased outpatient visits (r = .16, p = .025), emergency room
visits (r = .16, p = .028) and quantity of medications used (r = .20, p = .013) (Lebel, Tomei,
Feldstain, Beattie, & McCallum, 2013). In particular, both younger and female survivors
reported greater fear of recurrence, more visits to health care professionals and medication
utilization (female survivors only) (Lebel et al., 2013). Overall results suggest that younger,
female cancer survivors reported greater fear of cancer recurrence and greater health care
utilization (Lebel et al., 2013).
A randomized controlled trial of 84 breast cancer survivors from Tampa, Florida
examined the effects of a 6-week Mindfulness Based Stress Reduction (MBSR) program as an
intervention for psychological stressors (perceived stress, anxiety, depression, fear of recurrence)
and physical symptoms (pain, fatigue, sleep disturbances) in early breast cancer survivorship
(Lengacher et al., 2009). This is the first intervention study using MBSR as an intervention for
reducing fear of breast cancer recurrence (Lengacher et al., 2009). Subjects in the MBSR
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intervention group demonstrated lower scores at 6-weeks compared to the usual care group in
fear of recurrence (p = 0.007), fear of recurrence problems (p = 0.01), state anxiety (p =0.03),
trait anxiety (p = 0.004) and depression (p = 0.03) (Lengacher et al., 2009).
Another intervention study of 19 women post breast cancer treatment from Tampa,
Florida assessed the impact of an 8-week MBSR program as an intervention for fear of
recurrence, perceived stress, anxiety, and depression and physical symptoms (Lengacher et al.,
2011). This study was designed to assess the feasibility of an 8-week MBSR program on
psychological, physical symptoms and quality of life in early breast cancer survivorship. The
intervention of the 8-week MBSR program demonstrated a reduction in fear of recurrence (p =
.01), fear of recurrence concerns (p = .04), state anxiety (p = .09), trait anxiety (p = .01),
depression (p = .009) and perceived stress (p = .01) (Lengacher et al., 2011).
In summary, FOR remains a predominate concern for women post treatment for breast
cancer and into survivorship (Costanzo et al., 2007; Ferrell et al., 1997; Lebel et al., 2007; Van
den Beuken-van Everdingen et al., 2008). As discussed in the earlier studies, age, physical
symptoms and anxiety were associated with fear of recurrence (Ferrell et al., 1997; Lebel et al.,
2013; Lengacher et al., 2009; Menhert et al., 2009; Taylor et al., 2011; Vickberg, 2003). In one
study younger patients experienced greater FOR and more health care utilization (Lebel et al.,
2013) suggesting that there is a relationship between health-related anxiety and increased health
care utilization and health care costs (Lebel et al., 2013; Barsky, Ettner, Horsky, & Bates, 2001).
Other studies revealed that higher levels of education (Costanzo et al., 2007; Van den Beukenvan Everdingen et al., 2008) and patients who received mastectomy (Costanzo et al., 2007)
reported greater FOR contradicting findings from previous cited studies where these factors were
associated with lower FOR.
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Summary
It is evident in the empirical research reviewed that fear of breast cancer recurrence is a
legitimate and consistent concern among breast cancer survivors in the short and long term.
Younger age, limited education, increased fatigue, anxiety and depression are some of the more
common themes seen in the research to be associated with fears of cancer recurrence. However,
there tends to be preliminary findings that some of these factors may be influenced by age,
race/ethnicity and psychological influences such as social support and coping skills. Several
studies demonstrated that increased psychological concerns, like fear of recurrence particularly
in younger women resulted in more medical visits hence driving up the costs of health care. It is
clear from these findings and the qualitative requests from the women in these studies that there
is substantial opportunity for early screening and intervention related to fear of recurrence and
the associated factors.
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Chapter Three
Methods
This chapter outlines the research methods and procedures used for this study. The first
section discusses the research design followed by the methods, setting, population and sample,
recruitment, instrumentation and data analysis procedures.
Design
A cross-sectional research design was used to conduct a secondary data analysis among
82 women who were post treatment for breast cancer. The original parent study was an R-21
NCI funded (grant #R21CA109168), randomized controlled intervention trial examining the
Effects of Mindfulness Based Stress Reduction in Early Stage Breast Cancer Recovery
(Lengacher et al., 2009). The current study utilizes the baseline data from the R-21 study for a
secondary data analysis examining the relationship between stable, non-modifiable trait factors
and transient, modifiable state factors on fear of cancer recurrence in breast cancer survivors.
See Figure 1 in the Theoretical Framework section.
Setting and Subjects. Study subjects were recruited from the H. Lee Moffitt Cancer
Center and Research Institute at the University of South Florida in Tampa, Florida. The H. Lee
Moffitt Cancer Center is a National Cancer Institute and a nationally recognized Cancer Center
of Excellence for the diagnosis and treatment of breast cancer. The center’s catchment area
includes nearly 3 million people and serves the largest population of breast cancer patients in the
greater metropolitan area of Tampa, Florida. Recruitment for the parent study started March 1,
2006; all data collection was completed July 23, 2007.
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Inclusion/Exclusion Criteria. This study sample consists of 82 women age 21 or older
who were diagnosed with breast cancer Stage 0, I, II, III and had undergone surgery
(lumpectomy), received adjuvant radiation and/or chemotherapy and were within 18 months post
treatment. Other inclusion criteria included the ability to read and speak English at an 8th grade
level in order to respond to survey questions. Exclusion criteria included subjects advanced
stage breast cancer (Stage IV), history of prophylactic mastectomy prior to current breast cancer
treatment, severe psychiatric diagnoses and recurrent treatment for prior breast cancer.
Power Analysis. Prior to initiation of this study, the available sample size was reviewed
with respect to the specific aims to estimate statistical power and ability to draw reliable
inferences from the analysis. For specific aims 1 and 2, the primary analytical method used
consisted of Pearson or Spearman correlation coefficients (depending on statistical properties of
the continuous variables being evaluated), or analysis of variance (ANOVA) for comparisons of
means between levels of categorical variables. In these analyses, fear of recurrence, an
approximately normally distributed continuous variable was the dependent variable of interest.
Potential predictors of interest consisted of non-modifiable trait factors and modifiable state
factors that may be associated with fear of recurrence.
In correlation analyses, a sample size of 82 subjects provided 80% power (2-sided type I
error rate of 0.05) to detect a “modest” non-zero correlation coefficient of 0.303 or higher. For
ANCOVA, the power estimation assumed that 2 variables are adjusted for in the model that
collectively account for 10% of the variation (R2) in ratings of fear of recurrence. With a fixed
sample size of 82 subjects and 2-sided type I error rate of 0.05, the study provided 80% power to
detect an R2 value of 0.0786 attributed to one additional independent variable (e.g. a modifiable
state factor). This corresponds to a modest correlation coefficient of 0.28 indicating that the
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analysis was adequately powered to detect a modest effect size. Thus, the sample size of 82
subjects provided sufficient power to reliably examine specific aims 1 and 2.
For specific aim 3, statistical power was influenced by the correlation (unknown)
between the independent variable of interest and mediating variable of interest. With a sample
size of 82 subjects, assuming 2-sided type I error rate of 0.05 and a modest correlation of 0.30
between the independent variable and mediating variable (with variance of 1), the study provided
80% power to detect a standardized beta coefficient of 0.32 or higher. This corresponds to a
partial R2 value of 0.10, again indicating adequate power for the analysis.
Instrumentation
The following instruments were used to measure the antecedent, mediator and the
primary outcome variable:
Antecedent Variables
Demographic data were obtained using the Demographic Data Form (Lengacher
et al., 2009) to capture participant socio-economic demographic data for a description to
be the study sample. Data gathered included age, race/ethnicity, education, marital
status, and employment status.
Clinical History data were obtained using the Clinical History Form (Lengacher
et al., 2009) to capture cancer stage at time of diagnosis, treatment type, history of
hormone use, family history of breast cancer, social/behavioral history, including
exercise habits, history of alcohol, and tobacco use.
Mediator Variables
Physiologic Symptom data (Pain, Fatigue and Disturbed Sleep) were measured
using the M.D. Anderson Symptom Inventory (Cleeland et al., 2000). This is a self-
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administered questionnaire measuring current symptoms and severity of symptoms
experienced by the patient. The scale consists of 13-symptom items rated on presence and
severity and 6-symptom interference items that are rated on level of symptom
interference with function. For the purposes of this study only the subscales in the first
section of the instrument that measures symptoms in the last 24 hours will be used. Each
of the subscales consists of one item for each variable (pain, fatigue and disturbed sleep)
rated on Likert-type scale from 0 (not present) to 10 (as bad as you can imagine)
(Cleeland et al., 2000). Construct validity has been evidenced by principal factor analysis
using data from the initial outpatient sample (cross-validation sample) and demonstrated
high correlations with independent indicators of general symptom severity factors and
gastrointestinal factors. The internal reliability consistency ranges from 0.82 – 0.94
(Cleeland et al., 2000).
Depression was measured using the Center for Epidemiological Studies
Depression Scale (CES-D) (Radloff, 1977). This is a 20-item instrument that measures
depressive symptoms. Respondents rate on a 4-point scale the frequency of their
depressive symptoms within the past week (Radloff, 1977). Items are rated from (0)
rarely or none of the time to (3) most or all of the time. The scoring provides a total
depression score with a range from 0 to 60 of experienced symptoms (0 = not at all to 1
day a week for all 20 items ranging to 60 = 5 to 7 days a week) with the higher scores
indicating greater depressive symptoms (Radloff, 1977). The CES-D has demonstrated
concurrent validity by clinical and self-report criteria and construct validity (Radloff,
1977). The Cronbach alpha value for the CES-D is 0.92 for breast cancer subjects
(Radloff, 1977).
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Perceived Stress was measured using the Perceived Stress Scale (Cohen,
Kamarck, & Mermelstein, 1983). This is a 10-item Likert-type instrument that measures
“how often in the past month one appraises life situations as stressful” (Cohen et al.,
1983). Items are scored as (0) Never to (4) Very often. Construct and predictive validity
has been established with the Perceived Stress Scale and the CES-D and life events
scales. The internal consistency and reliability for the Perceived Stress Scale ranged
from 0.84 – 0.86 (Cohen et al., 1983).
Trait and State Anxiety was measured using the State Trait Anxiety Inventory
(Spielberger et al., 1983). This instrument contains two 20-item Likert-type scales that
measures both state anxiety (Y1-present experience of anxiety), and is scored as: Not at
all, Somewhat, Moderately so, Very much so. Trait anxiety (Y2-trait anxiety the
potential of the individual to experience anxiety symptoms when confronted with a
threatening situation), scored as: Not at all, Sometimes, Often, Almost always).
Concurrent, convergent, divergent and construct validity was represented using
contrasted groups, correlations of T-Anxiety scale with other measures of trait anxiety,
correlations of the STAI scales with other measures of personality and adjustment and
also academic aptitude and achievements and investigations of the effects of different
amounts and types of stress on S-Anxiety scores (Spielberger et al., 1983). The internal
consistency reliability for the State Trait Anxiety Scale is 0.95 (Spielberger et al., 1983).
Outcome Variable
Fear of Recurrence was measured using the Concerns about Recurrence Scale
(CARS) (Vickberg, 2003). This is a 30-item Likert-type instrument that measures the
extent and nature of women’s fears about the possibility of breast cancer recurrence.
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Comprised of 2 subscales overall fear of recurrence and worries related to recurrence.
The first section contains 4 items that assesses the overall fear of recurrence, with the
scoring (1) “I don’t think about it at all” to (6) “I think about it all the time” (Vickberg,
2003). The second subscale has four subscales comprising 26-items that assesses “what
it is” and extent to which they worry about each item regarding death worries, health
worries, role worries, role worries and womanhood worries. The overall fear index was
found to have a high internal consistency (α =.87) and significantly correlated with all
four CARS subscales: Death (r = .64); Health (r = .64); Roles, (r= .50), and Womanhood
(r = .53) (all correlations p < .0001) (Vickberg, 2003). Scoring for the second section is
on a 5-point scale ranging from (0) not at all to (4) extremely (Vickberg, 2003).
Convergence validity was determined comparing CARS to the Intrusive Thoughts and
Avoidance Subscales of the Impact Events Scales (IES) and the Distress and Well-Being
subscales of the Mental Health Inventory (MHI) (Vickberg, 2003). Internal consistency
for Concerns about Recurrence Scale is 0.87 for breast cancer subjects (Vickberg, 2003).
Procedures
Approval. Approval for this study was granted by the Institutional Review Board at the
University of South Florida (See Appendices) as a modification to the original study, Effects of
Mindfulness Based Stress Reduction in Early Stage Breast Cancer Recovery. This research
study analyzes de-identified data collected during 2006 and 2007 R-21 NCI study.
Data Collection Procedures. The current study is utilizing the secondary baseline data
set from the R-21 (NCI Grant #R21CA109168) Effects of Mindfulness Based Stress Reduction
in Early Stage Breast Cancer Recovery (Lengacher et al., 2009). Several recruitment methods
were used for the parent study including introduction of the study by healthcare practitioners at
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the H. Lee Moffitt Cancer Center in addition to brochures and flyers distributed throughout the
cancer center. Patients who expressed interest in the study were asked to complete a HIPAA
authorization form that indicated their willingness to be contacted by a member of the trained
research team. Interested subjects were provided with an orientation session within the 6 weeks
to 6 months post treatment for breast cancer that is the transition period from conventional
treatment to adaptation and return to routine daily life and activities. During the orientation
session study details were explained, informed consent was obtained, and patients were
randomized into the different groups (as a note, in order to maximize enrollment subjects who
were randomized to the control group were offered the opportunity to receive the intervention
after a wait period). All subjects provided written consent and subjects received nominal
compensation for their time of $50 at the completion and end of the study participation.
Data Management. Statistical Product and Service Solutions (SPSS) Version 21.0 was
utilized for all data entry, data management and analysis related to this study. Data were deidentified and stored in password protected files secured in the investigator’s office to maintain
confidentiality. Results were reported using only de-identified data and without patient
identifiers.
Data Analysis. Data analysis was performed using quantitative statistical procedures in
SPSS Version 21.0. The primary outcome variable fear of recurrence (CARS Overall Fear and
CARS Nature of Worry) was analyzed three ways using Pearson’s correlations, ANOVA and
mediation analysis.
Aim #1 – univariate analysis was used to evaluate the relationship between the
antecedent variable (non-modifiable trait factors) including demographic information,
clinical history, social/behavioral history and outcome variable, fear of breast cancer
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recurrence (CARS overall fear and CARS nature of worry). The dependent variable of
interest, fear of breast cancer recurrence, was measured on continuous scale and therefore
initially the univariate association was examined by correlation coefficients for
continuous covariates and analysis of variance for categorical variables. See Figure 2 and
3.

Outcome Variable

Antecedent Variable

Fear of Breast Cancer
Recurrence

Trait Factors
Demographic
Age
Race/Ethnicity
Education
Marital Status
Employment Status
Clinical History
Stage of cancer
Family history of
breast cancer
Hormone use
Trait Anxiety
Social/Behavioral History
Exercise
History of smoking
Alcohol use

CARS Overall Fear

Top 2 strongest independent
trait factors identified
Note: Two factors chosen due to
sample size.

Figure 2. Model for Aim #1
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Antecedent Variable

Outcome Variable

Trait Factors
Demographic
Age
Race/Ethnicity
Education
Marital Status
Employment Status
Clinical History
Stage of cancer
Family history of
breast cancer
Hormone use
Trait Anxiety
Social/Behavioral History
Exercise
History of smoking
Alcohol use

Fear of Breast Cancer
Recurrence
CARS Nature of Worry

Top 2 strongest independent
trait factors identified
Note: Two factors chosen due to
sample size.

Figure 3. Model for Aim #1

Aim #2 – univariate analysis was used to evaluate the relationship between mediator
variable (modifiable state factors) such as anxiety, depression, perceived stress, pain, fatigue and
sleep disturbances and the outcome variable, fear of recurrence (CARS overall fear and CARS
nature of worry). The dependent variable of interest, fear of breast cancer recurrence, was
measured on continuous scale and therefore initially the univariate association is examined by
correlation coefficients for continuous covariates.
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Figure 4. Model for Aim #2

Figure 5. Model for Aim #2
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Aim #3 - assesses state factors that may mediate the effect on the relationships between
antecedent trait factors and the outcome variable fear of recurrence. The conceptual framework
(Figure 1) lists postulated mediating variables. Briefly, mediating variables are those that may
help to explain “how” state factors mediate (influence) the relationship between the antecedent
variable, trait factors and the outcome variable, fear of recurrence. This analytic approach for
conducting this type of analysis is depicted in the diagram below. See Figure 6 and 7.
In Figure 6 and 7, trait factors (X1) are assumed to have both a direct and indirect path to
the outcome of fear of breast cancer recurrence. “c” is the direct path, and “a to b” is the
indirect path, passing through the mediating variable X2 (state factors). The statistical approach
to assess mediating effects was first to identify the significant univariate relationships, such as
trait factors (i.e. “X1”) that are associated with fear of breast cancer recurrence (i.e. “Y”). The
next step adds a potential mediator (state characteristics: “X2”) to the model a linear regression
procedure using the Preacher and Hayes (2008) method of assessing the indirect effects in a
simple mediation model with bootstrapping of 5,000 iterations to obtain unbiased estimates from
the sample of 82, to the extent possible, of the indirect effects of the potential mediating
variables.
If the X2 to Y relationship is strong, yet the X1 to Y relationship is substantially
attenuated, this is considered an indication that variable X2 is a mediator of the relationship X1
to Y (i.e. X1 to X2 to Y). There also exists the possibility that X1 and X2 are so strongly
correlated that they cannot survive in the model together, but in this case, the significance levels
of both X1 and X2 are attenuated when they are evaluated simultaneously.
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Figure 6. Model for Aim #3

Figure 7. Model for Aim #3
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Chapter Four
Results
This chapter summarizes the study findings of factors associated with the fear of breast
cancer recurrence (CARS overall fear and CARS nature of worry) and the mediating effects of
the mediator variables (modifiable state factors) on the antecedent variables (trait factors). The
results are presented by each of the three research aims.
Sample
The sample size of 82 women post-treatment for breast cancer participated in the study
from the H. Lee Moffitt Cancer and Research Institute in Tampa, Florida from March 1, 2006 to
July 23, 2007. In the original R-21 study 200 women were pre-screened and approached for the
study, 7 were ineligible, and 109 declined participation for a variety of reasons ranging from not
interested, distance from home, transportation issues, family obligations and health issues. Two
of the participants were lost to follow up. This study used the baseline data for the secondary
analysis from the R-21 NCI funded randomized control trial. Eighty-two (N = 82) women
completed all the baseline tests comprising the final sample for this study and data analysis.
Participants were recruited from the H. Lee Moffitt Cancer Center and all participants
completed a demographic data form, clinical history form, Perceived Stress Scale (PSS), State
Trait Anxiety Inventory (STAI), M.D. Anderson Symptom Inventory (MDASI), Center for
Epidemiologic Studies Depression Scale (CES-D) and the Concerns About Recurrence Scale
(CARS) (CARS overall fear and CARS nature of worry) at their baseline assessment.
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The demographic assessment of the participants consisted of the following: age,
race/ethnicity, education, marital status and employment status. Tables 1 and 2 displays the
demographic characteristics for age with a mean age of 57 years (M = 57.18 SD + 9.136); the
majority of the subjects were greater than 55 years of age (59.7%) with the remaining subjects
being younger than 55 years of age (40.2%). Eighty seven percent (n=72) of the study
participants were White (White Hispanic, Ashkenazi Jewish, White non-Hispanic & Native
American) and 12.2% (n=10) were Black non-Hispanic. The majority of the women who
participated in the study were married (68.3%, n=56) and the rest of the women were unmarried
(31.7%, n=26) (divorced, never married or separated). Fifty eight percent (n=48) of the women
were employed at the start of the study and 41.5% (n=34) were not employed. The majority of
the women (67.1%) reported some level of higher education (n=55) including college, graduate
school or professional school; 23.2% of the women (n=19) reported some college or associate
degree completion, 20.7% (n=17) reported a college education, and 23.2% (n=19) graduate
school or professional schooling. The remaining subjects reported vocational education level
and lower, vocation beyond high school (11%, n=9), high school (17.1%, n=14) and some high
school (4.9%, n=4).

Table 1
Demographics Characteristics (Frequency, Percentage, Mean, Standard Deviation) (N=82)
Demographics
Frequency
Percent
Mean
SD
Age
57.18
9.136
< 55
33
40.2%
55-64
28
34.1%
65-75
20
24.4%
>75
1
1.2%
Race and Ethnicity
White non-Hispanic
59
72.0%
White Hispanic
9
11.0%
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Table 1 Continued
Black non-Hispanic
Ashkenazi Jewish
White non-Hispanic & Native American

10
2
2

12.2%
2.4%
2.4%

Table 2
Demographics Characteristics (Frequency, Percentage, Mean) (N=82)
Demographics
Frequency
Marital Status
Married
56
Not married
26
Employment
Employed
48
Unemployed
34
Education
Some High School
4
High School graduate
14
Vocation Beyond High School
9
Some College or Associates Degree
19
College
17
Graduate School or Professional school
19

Percent
68.3%
31.7%
58.5%
41.5%
4.9%
17.1%
11.0%
23.2%
20.7%
23.2%

Clinical history data were collected for each of the study participants at baseline
including stage of cancer at diagnosis, treatment history, history of hormone use, history of trait
anxiety and family history of breast cancer; Table 3 represents the frequency and percentage for
the study participant’s stage of cancer at diagnosis. The majority of the women were diagnosed
with early stages of cancer, Stage 0 (17.1%, n=14) and Stage I (52.4%, n=43) the remaining
women were diagnosed with Stage II (23.2%, n=19) and Stage III (7.3%, n=6). Of the 82
participants, 49 women (59.8%) received radiation only and 33 women (40.2%) received
radiation and chemotherapy. Eighty women responded to the question regarding history of
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hormone use. Seventy-two percent (n=58) of the women reported a history of hormone use
either for fertility, contraception or hormone replacement and 27.5% (n=22) denied any history
of hormone use. Of the 61 women who responded to the question about family history of breast
cancer, 77% (n=47) did not report a family history of breast cancer and 23% (n=14) reported a
family history of breast cancer in a mother, grandmother, sister or aunt.

Table 3
Clinical History Characteristics (Frequency and Percentage) (N=82)
Clinical History
Frequency
Stage (N=82)
Stage 0
14
Stage I
43
Stage II
19
Stage III
6
Treatment (N=82)
Radiation only
49
Radiation and Chemotherapy
33
Hormone Use (N=80)
Yes
58
No
22
Family History of Breast Cancer (N=61)
Yes
14
No
47

Percent
17.1%
52.4%
23.2%
7.3%
59.8%
40.2%
72.5%
27.5%
23.0%
77.0%

Social/Behavioral history including a history of smoking, alcohol use, beer, wine and
liquor consumption and the number of days per week exercised was also studied. Tables 4 and 5
describe the frequency and percentage for each of these variables. Of the 78 women who
responded to their frequency of exercise, 21 women (26.9%) reported no weekly exercise, 29
women (34.6%) exercised 3 days per week or less and 30 women (38.4%) exercised 4 days per
week or more. The average number of days exercised was 2.77 (M = 2.77 SD + 2.62) days per
week. Of the 81 women who responded, the majority of the women were non-smokers (n=43,
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53.1%), 43.2% (n=35) of the women reported being a former smoker and three women (3.7%)
were current smokers. Eighty women who responded to the alcohol use question, 49 women
(61.3%) reported drinking alcohol and 31 (38.8%) denied drinking alcohol. Regarding
consumption of beer, 5 women (9.4%) reported being beer drinkers and 48 women (90.6%) were
not, 27 women (47.4%) reported drinking wine and 30 women (52.6%) did not drink wine, lastly
6 women (11.3%) reported drinking liquor and 47 women (88.7%) reported no liquor
consumption.
Table 4
Social/Behavioral History (Frequency, Percentage, Mean and Standard Deviation)
Social/Behavioral History
Frequency
Percent
Mean
SD
Days of Exercise (N=78)
2.77
2.62
0 days
21
26.9%
1 days
5
6.4%
2 days
10
12.8%
3 days
12
15.4%
4 days
11
14.1%
5 days
9
11.5%
6 days
4
5.1%
7 days
6
7.7%
Smoking History (N=81)
Current Smoker
3
3.7%
Former Smoker
35
43.2%
Non-Smoker
43
53.1%

Table 5
Social/Behavioral History (Frequency and Percentage)
Social/Behavioral History
Frequency
Alcohol Consumption (N=80)
Yes
49
No
31
Beer Consumption (N=53)
Yes
5
No
48
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Percent
61.3%
38.8%
9.4%
90.6%

Table 5 Continued
Wine Consumption (N=57)
Yes
No
Liquor Consumption (N=53)
Yes
No

27
30

47.4%
52.6%

6
47

11.3%
88.7%

Table 6 lists the means and standard deviations for all the continuous and discrete
variables including the antecedent (non-modifiable trait factors), mediator variables (modifiable
state factors) and the outcome variable fear of recurrence for the study sample of 82 women.
Antecedent Variable
The only continuous antecedent variable measured on a Likert-type scale is displayed in
Table 6 was trait anxiety and was measured using the State Trait Anxiety Index. The sample of
82 women yielded a mean score of (M = 36.88 SD + 8.53). Compared to the general population
of women ages 50-69 (M = 31.79) (Spielberger et al., 1983) this corresponded to a z-score in the
72nd percentile of the distribution of trait anxiety scores.
Mediator Variables
The mediator variables (modifiable state factors) displayed in Table 6 included
depression, perceived stress, state anxiety, pain, fatigue, sleep disturbances and fear of
recurrence for the sample of 82 women. Depression was measured using the Center for
Epidemiologic Studies Depression Scale for this study sample yielding a mean score of (M =
10.49 SD + 9.09). Compared to the general population (M = 9.25) (Radloff, 1977) this
corresponded to a z-score in the 55th percentile of the distribution of depression scores.
Perceived stress was measured using the Perceived Stress Scale resulting in a mean score of (M =
15.15 SD + 7.09). Compared to the general population (M = 11.9) (Cohen et al., 1983) this
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corresponded to a z-score in the 68th percentile of the distribution of perceived stress scores.
State anxiety was measured using the State Trait Anxiety Index resulting in a mean score of (M =
33.71 SD + 11.39). Compared to the general population of women ages 50-69 (M = 32.20)
(Spielberger et al., 1983), this corresponds to a z-score in the 55th percentile of the distribution of
state anxiety scores. Thus on average, women in study scored modestly higher on psychological
measures of anxiety, depression and stress compared to women of similar age in the general
population. Pain, fatigue and disturbed sleep were all measured using the subscales of the M.D.
Anderson Symptom Inventory. Pain yielded a mean score of (M = 1.90 SD + 2.26), fatigue
resulted a mean score (M= 3.57 SD + 2.74) and sleep disturbances had a mean score of (M = 3.16
SD + 3.18). Population comparisons were not available but based on instrument scales pain,
fatigue and sleep appear to be low to moderate.
Outcome Variable
Fear of recurrence was measured using the Concerns About Recurrence Scale that
consists of two scales, Concerns About Recurrence Overall Fear (CARS overall fear) and
Concerns About Recurrence Nature of Worry (CARS nature of worry). Table 6 displays the
results for the mean and standard deviations for the CARS overall fear (M = 11.11 SD + 4.89)
and the CARS nature of worry (M = 32.41 SD + 22.31). Population comparisons were not
available but based on the instrument scales revealing fear of recurrence overall and nature of
fears were moderate.
In summary, the women in this study at baseline reported higher trait, state anxiety,
depression and perceived stress than the general population and low to moderate symptoms of
pain, fatigue and sleep disturbances. At baseline, the study participants expressed low to
moderate concerns regarding fear of cancer recurrence (CARS overall fear and CARS nature of
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worry).

Table 6
Antecedent, Mediator and Outcome Variables (Means and Standard Deviations) (N=82)
Variable
Range
Mean
SD
Trait Anxiety
24.00 to 63.00
36.88
8.53
Depression
.00 to 41.00
10.49
9.09
Perceived Stress
2.00 to 33.00
15.15
7.09
State Anxiety
20.00 to 70.00
33.71
11.39
Pain
.00 to 10.00
1.90
2.26
Fatigue
.00 to 10.00
3.57
2.74
Sleep Disturbances
.00 to 10.00
3.16
3.18
Concerns About Recurrence Overall
Fear
4.00 to 24.00
11.11
4.89
Concerns About Recurrence Nature of
Worry
.00 to 98.00
32.41
22.31

Research Aim Number One
Research aim one explores the relationship between the antecedent variables (trait
factors) and fear of recurrence (CARS overall fear and CARS nature of worry). Table 7 and 8
represents the Pearson’s and Spearman’s correlations conducted for the continuous and discrete
antecedent variables and the outcome variable fear of recurrence (CARS overall fear). The
findings suggest statistical significance that age (r = -.236, p = .033) was negatively associated
with fear of recurrence (CARS overall fear) meaning as age increases, fear of recurrence
decreases. In addition, trait anxiety (r = .433, p = .000) was positively associated with fear of
recurrence (CARS overall fear), meaning as trait anxiety increases, fear of recurrence increases.
Education, stage and exercise were not found to be associated with fear of recurrence in this
study sample.
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Table 7
Correlations of Parametric Antecedent Variables and Concerns About Recurrence Overall Fear
Antecedent Variables
N
Pearson (r)
p-value
Age
82
-.236
.033
Trait Anxiety
82
.433
.000
Exercise
78
-.072
.534

Table 8
Correlations of Nonparametric Antecedent Variables and Concerns About Recurrence Overall
Fear
Antecedent Variables
N
p-value
Spearman (𝜌)
Education
82
-.152
.172
Stage
82
.057
.610

Table 9 and 10 represents the Pearson’s and Spearman’s correlations conducted for the
continuous and discrete antecedent variables within the demographics, clinical and
social/behavioral history and the outcome variable fear of recurrence (CARS nature of worry).
The findings suggest statistical significance that age (r = -.269, p = .015) was negatively
associated with fear of recurrence (CARS nature of worry) meaning as age increases fear of
recurrence (CARS nature of worry) decreases. Additionally, trait anxiety (r = .358, p = .001) was
positively associated with fear of recurrence (CARS nature of worry) meaning as trait anxiety
increases fear of recurrence (CARS nature of worry) increases. Education, stage and exercise
were not found to be associated with fear of recurrence in this study sample.

Table 9
Correlations of Antecedent Variables and Concerns About Recurrence Nature of Worry
Antecedent Variables
N
Pearson (r)
p-value
Age
82
-.269
.015
Trait Anxiety
82
.358
.001
Exercise
78
-.042
.713
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Table 10
Correlations of Nonparametric Antecedent Variables and Concerns About Recurrence Nature of
Worry
Antecedent Variables
N
p-value
Spearman (𝜌)
Education
82
-.184
.098
Stage
82
.196
.078

Analysis of variance (ANOVA) was used to evaluate the relationship between the
categorical antecedent variable (non-modifiable trait factors) including race/ethnicity, marital
status, employment status, treatment type, smoking, alcohol use, hormone use, family history of
breast cancer and the outcome variable (fear of breast cancer recurrence).
Table 11 displays the results for the means and standard deviations for the dependent
variable fear of recurrence using the CARS overall fear scale and categorical antecedent
variables (demographics). The means were not significantly different for being White (M =
11.27 SD + 4.45) and being non-White (M = 10.70 SD + 8.11) with a p-value of .635. Table 21
displays the results for the means and standard deviations for the dependent variable fear of
recurrence using the CARS overall fear scale and marital status. The means were not
significantly different for marital status, married (M = 11.50 SD + 4.57) and for not married (M =
11.11 SD + 4.89) with a p-value of .292. The means were not significantly different for
employment status, employed (M = 11.73 SD + 4.39) and unemployed (M = 10.24 SD + 4.02)
with a p-value of .175.
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Table 11
ANOVA Demographics and Concerns About Recurrence Overall Fear
Demographics
N
Mean
SD
95% CI for Mean
Lower
Upper
Bound
Bound
Ethnicity and Race
White
59
11.27
4.45
10.11
12.43
Non-White
23
10.70
5.98
8.11
13.28
Total
82
11.11
4.89
10.03
12.19
Marital Status
Married
56
11.50
4.57
10.28
12.72
Not Married
26
10.27
5.52
8.04
12.50
Total
82
11.11
4.89
10.03
12.19
Employment
Employed
48
11.73
4.39
10.17
13.29
Unemployed
34
10.24
4.02
8.83
11.64
Total
82
11.11
4.89
10.03
12.19
C.I. = Confidence Interval
Note: Each variable evaluated separately

p-value

.635

.292

.175

Table 12 displays the results for the means and standard deviations for the dependent
variable fear of recurrence using the CARS overall fear scale and the categorical antecedent
variables (clinical history). Means were not significantly different by treatment type, radiation
(M = 11.27 SD + 5.15) and for radiation and chemotherapy (M = 10.88 SD + 12.49) with a pvalue of .728. The means were not significantly different for hormone use (M = 11.26 SD +
5.07) and no hormone use (M = 11.00 SD + 4.66) with a p-value of .863. The means were not
significantly different for family history of breast cancer (M = 10.86 SD + 5.35) and no family
history of breast cancer (M = 11.26 SD + 4.88) with a p-value of .794.
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Table 12
ANOVA Clinical History and Concerns About Recurrence Overall Fear
Clinical History
N
Mean
SD
95% CI for Mean
Lower
Upper
Bound
Bound
Treatment
Radiation
49
11.27
5.15
9.79
12.74
Radiation and
33
10.88
4.55
9.26
12.49
Chemotherapy
Total
82
11.11
4.89
10.03
12.19
Hormone Use
Yes
58
11.26
5.07
9.93
12.59
No
22
11.00
4.66
8.93
13.07
Total
80
11.19
4.93
10.09
12.28
Family History of Breast
Cancer
Yes
14
10.86
5.35
7.77
13.94
No
47
11.26
4.88
9.82
12.69
Total
61
11.16
4.95
9.90
12.43
C.I. = Confidence Interval
Note: Each variable evaluated separately

p-value

.728

.836

.794

Table 13 and 14 displays the results for the means and standard deviations for the
dependent variable fear of recurrence using the CARS overall fear scale and antecedent variables
(social/behavioral history). The means were not significantly different smoking history,
currently smoking (M = 12.00 SD + 10.58), former smoker (M = 11.60 SD + 4.72) and nonsmoker (M = 10.72 SD + 4.91) with a p-value of .706. The means were not significantly
different for alcohol use (M = 10.84 SD + 4.58) and no alcohol use (M = 11.81 SD + 5.41) with a
p-value of .393. The means were not significantly different for alcohol use, drinking beer (M =
9.00 SD + 4.00) and not drinking beer (M = 11.50 SD + 4.92) with a p-value of .278;
drinking wine (M = 10.48 SD + 4.22) and not drinking wine (M = 12.33 SD + 5.73) with a pvalue of .175; drinking liquor (M = 12.33 SD + 4.80) and not drinking liquor (M = 11.28 SD +
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4.95) with a p-value of .623.
Table 13
ANOVA Social/Behavioral History and Concerns About Recurrence Overall Fear
Social/Behavioral
N
Mean
SD
95% CI for Mean
History
Lower
Upper
Bound
Bound
Smoking History
Current Smoker
3
12.00 10.58
-14.29
38.29
Former Smoker
35
11.60
4.72
9.98
13.22
Non-Smoker
43
10.72
4.70
9.27
12.17
Total
81
11.15
4.91
10.06
12.23
C.I. = Confidence Interval
Note: Each variable evaluated separately
Table 14
ANOVA Social/Behavioral History and Concerns About Recurrence Overall Fear
Social/Behavioral
N
Mean
SD
95% CI for Mean
History
Lower
Upper
Bound
Bound
Alcohol Use
Yes
49
10.84
4.58
9.52
12.15
No
31
11.81
5.41
9.82
13.79
Total
80
11.21
4.91
10.12
12.30
Beer Consumption
Yes
5
9.00
4.00
4.03
13.97
No
48
11.50
4.92
10.07
12.93
Total
53
11.26
4.86
9.92
12.60
Wine Consumption
Yes
27
10.48
4.22
8.81
12.15
No
30
12.33
5.73
10.19
14.47
Total
57
11.45
5.11
10.10
12.81
Liquor Consumption
Yes
6
12.33
4.80
7.29
17.37
No
47
11.28
4.95
9.82
12.73
Total
53
11.40
4.90
10.05
12.75
C.I. = Confidence Interval
Note: Each variable evaluated separately
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p-value

.706

p-value

.393

.278

.175

.623

Table 15 displays the results for the means and standard deviations for the dependent
variable fear of recurrence using the CARS nature of worry scale and categorical antecedent
variables (demographics). The means were not significantly different for being White (M = 31.89
SD + 19.86) and non-White (M = 33.74 SD + 28.11) with a p-value of .738. The means were not
significantly different for marital status, married (M = 33.14 SD + 20.34) and unemployed (M =
30.82 SD + 26.44) with a p-value of .664. The means were not significantly different for
employment status, employed (M = 33.69 SD + 24.43) and unemployed (M = 30.60 SD + 19.13)
with a p-value of .540.
Table 15
ANOVA Demographics and Concerns About Recurrence Nature of Worry
Demographics
N
Mean
SD
95% CI for Mean
Lower
Upper
Bound
Bound
Race and Ethnicity
White
59
31.89
19.86
26.71
37.06
Non-White
23
33.74
28.11
21.59
45.89
Total
82
32.41
22.31
27.51
37.31
Marital Status
Married
56
33.14
20.34
27.70
38.59
Not Married
26
30.82
26.44
20.15
41.50
Total
82
32.41
22.31
27.51
37.31
Employment Status
Employed
48
33.69
24.43
26.59
40.78
Unemployed
34
30.60
19.13
23.92
37.28
Total
82
32.41
22.31
27.51
37.31
C.I. = Confidence Interval
Note: Each variable evaluated separately

p-value

.738

.664

.540

Table 16 displays the results for the means and standard deviations for the dependent
variable fear of recurrence using the CARS nature of worry scale and the categorical antecedent
variables (clinical history). The means were not significantly different for treatment type,
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radiation (M = 29.78 SD + 20.90) and radiation and chemotherapy (M = 36.30 SD + 24.05) with
a p-value of .196. The means were not significantly different for hormone use (M = 32.21 SD +
21.63) and no hormone use (M = 34.05 SD + 24.93) with a p-value of .747. The means were not
significantly different for family history of breast cancer (M = 31.36 SD + 22.89) and no family
history of breast cancer (M = 33.29 SD + 23.14) with a p-value of .785.

Table 16
ANOVA Clinical History and Concerns About Recurrence Nature of Worry
Clinical History
N
Mean
SD
95% CI for Mean
Lower
Upper
Bound
Bound
Treatment
Radiation
49
29.78
20.90
23.78
35.79
Radiation and
33
36.30
24.05
27.78
44.83
Chemotherapy
Total
82
32.41
22.31
27.51
37.31
Hormone Use
Yes
58
32.21
21.63
26.53
37.90
No
22
34.05
24.93
22.99
45.10
Total
80
32.72
22.43
27.73
37.71
Family History of Breast
Cancer
Yes
14
31.36
22.89
18.14
44.58
No
47
33.29
23.14
26.49
40.08
Total
61
32.84
22.91
26.98
38.71
C.I. = Confidence Interval
Note: Each variable evaluated separately

p-value

.196

.747

.785

Table 17 and 18 displays the results for the means and standard deviations for the
dependent variable fear of recurrence using the CARS nature of worry Scale and antecedent
variables (social/behavioral history). The means were not significantly different for currently
smoking (M = 36.33 SD + 37.07), former smoker (M = 34.11 SD + 22.98) and non-smoker (M =
30.78 SD + 21.46) with a p-value of .775; alcohol use (M = 30.06 SD + 21.58) and no alcohol
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use (M = 36.79 SD + 23.61) with a p-value of .194; drinking beer (M = 24.60 SD + 15.87) and
not drinking beer (M = 32.51 SD + 20.87) with a p-value of .416; drinking wine (M = 28.74 SD
+ 18.86) and not drinking wine (M = 23.81 SD + 23.65) with a p-value of .221; and drinking
liquor (M = 37.67 SD + 24.68) and not drinking liquor (M = 32.20 SD + 20.31) with a p-value of
.547.

Table 17
ANOVA Social/Behavioral History and Concerns About Recurrence Nature of Worry
Social/Behavioral
N
Mean
SD
95% CI for Mean
p-value
History
Lower
Upper
Bound
Bound
Smoking History
Current Smoker
3
36.33
37.07
-55.76
128.43
Former Smoker
35
34.11
22.98
26.22
42.00
Non-Smoker
43
30.78
21.46
24.17
37.38
Total
81
32.42
22.45
27.46
37.39
.775
C.I. = Confidence Interval
Note: Each variable evaluated separately
Table 18
ANOVA Social/Behavioral History and Concerns About Recurrence Nature of Worry
Social/Behavioral
N
Mean
SD
95% CI for Mean
p-value
History
Lower
Upper
Bound
Bound
Alcohol Use
Yes
49
30.06 21.58
23.86
36.26
No
31
36.79 23.61
28.13
45.45
Total
80
32.67 22.48
27.66
37.67
.194
Beer Consumption
Yes
5
24.60 15.87
4.90
44.30
No
48
32.51 20.87
26.45
38.57
Total
53
31.76 20.46
26.12
37.40
.416
Wine Consumption
Yes
27
28.74 18.86
21.28
36.20
No
30
35.81 23.65
26.98
44.64
Total
57
32.46 21.62
26.72
38.20
.221
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Table 18 Continued
Liquor Consumption
Yes
6
37.67 24.68
No
47
32.20 20.31
ANOVA Continued
Total
53
32.82 20.65
C.I. = Confidence Interval
Note: Each variable evaluated separately

11.77
26.24

63.57
38.16

27.13

38.51

.547

Aim one explored the relationship between the antecedent variables (trait factors) that
are typically non-modifiable attributes associated with fear of recurrence (CARS overall fear
and CARS nature of worry) using Pearson’s and Spearman’s correlations and analysis of
variance (ANOVA). The findings revealed that age was negatively associated with overall fear
of recurrence (r = -.236, p = .033) and fear of recurrence nature of worry (r = -.269, p = .015). In
addition, trait anxiety was associated with overall fear of recurrence (r = .433, p = .000) and fear
of recurrence nature of worry (r = .358, p = .001). Race/ethnicity, education, marital status,
employment, exercise, stage, treatment, exercise, smoking, drinking, hormone use and family
history of breast cancer were not found to be associated with fear of recurrence in this study
sample.
Research Aim Two
A univariate analysis was examined by correlation coefficients for continuous covariates
to evaluate the relationship between mediator variables (modifiable state factors) - psychological
symptoms such as state anxiety, depression, perceived stress and physiological symptoms such
as pain, fatigue, sleep disturbances and the outcome variable (fear of breast cancer recurrence).
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The dependent variable of interest, fear of breast cancer recurrence, was measured on continuous
scale using Pearson’s correlations.
Table 19 represents the Pearson’s correlations conducted for the continuous mediator
variables and the outcome variable fear of recurrence (CARS overall fear). The findings reveal
statistical significance that depression (r = .347, p = .001), state anxiety (r = .467, p = .000) and
perceived stress (r = .365, p = .001) were positively associated with fear of recurrence (CARS
overall fear).

Table 19
Correlations of Mediator Variables and Concerns About Recurrence Overall Fear (N=82)
Mediator Variables
Pearson (r)
p-value
Pain
.202
.069
Fatigue
.114
.308
Sleep disturbances
.162
.145
Depression
.347
.001
State Anxiety
.467
.000
Perceived Stress
.365
.001
Table 20 represents the correlations for the continuous mediator variables and the
outcome variable, concerns about recurrence nature of worry. Pearson’s correlations conducted
for the continuous mediator variables and the outcome variable fear of recurrence (CARS nature
of worry). The findings reveal statistical significance that pain (r = .220, p = .047), fatigue (r =
.247, p = .025), state anxiety (r = .369, p = .001) and perceived stress (r = .410, p = .000) were
positively associated with fear of recurrence (CARS nature of worry).
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Table 20
Correlations of Mediator Variables and Concerns About Recurrence Nature of Worry (N=82)
Mediator Variables
Pearson (r)
p-value
Pain
.220
.047
Fatigue
.247
.025
Sleep
.118
.292
Depression
.213
.055
State Anxiety
.369
.001
Perceived Stress
.410
.000

Aim two explored the relationship between the mediator variables (state factors),
typically modifiable attributes such as pain, fatigue, sleep disturbances, state anxiety, depression,
perceived stress associated with fear of recurrence (CARS overall fear and CARS nature of
worry) using Pearson’s correlations. Findings revealed that depression (r = .347, p = .001), state
anxiety (r = .467, p = .000), perceived stress (r = .365, p = .001) were associated with overall fear
of recurrence and pain (r = .220, p = .047), fatigue (r = .247, p = .025), state anxiety (r = .369, p
= .001), and perceived stress (r = .410, p = .000) were associated with fear of cancer recurrence
nature of worry.
Research Aim Three
Aim three assessed potential mediation effects of the mediating variables (modifiable
state factors), meaning the indirect effect of these variables on the direct relationship between
antecedent variables (non-modifiable trait factors) and the primary outcome variable, fear of
breast cancer recurrence. In this analysis, antecedent (trait) factors are assumed to have both a
direct (c' path) and indirect path (a path) to the outcome of fear of breast cancer recurrence
through the mediator variable (b path).
The linear regression method described by Preacher and Hayes (2008) was used to assess
the indirect effects of potential mediators in a simple mediation model. This approach was used
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to determine whether the specific state factors that were most correlated with fear of recurrence
(state anxiety, perceived stress and depression) mediated the relationship between the antecedent
(non-modifiable trait) factors that were most correlated with fear of recurrence. Given that age
and trait anxiety were correlated with both fear of recurrence scales (CARS overall fear and
CARS nature of worry), it was determined that having a single antecedent variable and one
mediator variable with the outcome variable would allow for the most reliable and interpretable
assessment of mediation. Therefore, in addition to examining age and trait anxiety separately as
antecedent variables, a composite of these 2 variables was created. Specifically, the standardized
Z-score for each variable was obtained and summed, thereby providing equal weight for the 2
variables combined in a single variable. This composite antecedent variable (age/trait anxiety)
was analyzed in separate mediation models with fear of recurrence for both CARS overall fear
and CARS nature of worry. Because of the relatively modest sample size, bootstrapping with
5,000 iterations was used to obtained unbiased estimates, to the extent possible, of the indirect
effects of the potential mediating variables.
The findings in Table 21 indicate that state anxiety mediates the relationship (has an
indirect effect) between trait anxiety and fear of recurrence (CARS overall fear). For these
results, the notation βa1b1 is used to denote the unstandardized beta coefficient for the mediating
variable representing the previously depicted a à b à Y path (i.e. indirect effect). With trait
anxiety as the antecedent variable, the indirect effect of state anxiety is statistically associated
with CARS overall fear (β = .1381, 95% CI = .0053 - .3050, p = .0299). Similarly, with the
composite age/trait anxiety antecedent variable, state anxiety is statistically associated with
CARS overall fear (β = .5579, 95% CI = .1201 - 1.1669, p = .0157). The standardized z- scores
for state anxiety were 2.1718 and 2.4159 respectively for the models with trait anxiety alone
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versus the composite z-score of age/trait anxiety as the antecedent variable. Therefore, inclusion
of age with trait anxiety nominally influenced (improved) the strength of relationship with fear of
recurrence (CARS overall fear), as well as the indirect effect of state anxiety. Perceived stress
and depression were not statistically significant, and did not provide evidence of mediating the
relationship between trait anxiety, age/trait anxiety and concerns about recurrence (CARS overall
fear).

Table 21
Indirect Effects of Antecedent Variables on Concerns About Recurrence Overall Fear through
Mediator Variables (ab paths) (N = 82)
Variables
SE
z
p-value
β Coefficient
Antecedent Variable
Mediator Variable
Age
State Anxiety
-.0046
.0275
-.1682
.8664
Trait Anxiety
State Anxiety
.1381
.0636 2.1718
.0299*
Trait Anxiety and Age ** State Anxiety
.5579
.2309 2.4159
.0157*
Age
Perceived Stress
-.0144
.0211
-.6804
.4962
Trait Anxiety
Perceived Stress
.0517
.0530
.3288
.3288
Trait Anxiety and Age** Perceived Stress
.2897
.2191 1.3221
.1861
Age
Depression
.0029
.0209
.1373
.8908
Trait Anxiety
Depression
.0284
.0608
.4670
.6405
Trait Anxiety and Age** Depression
.2521
.2028
1.2433
.2137
* p < .05
S.E. = Standard Error
**Composite variable - converted to z-score to apply equal weight to each variable
Note: Each model evaluated separately
The findings in Table 22 indicate that perceived stress mediates the relationship (has an
indirect effect) between trait anxiety and fear of recurrence (CARS nature of worry). For these
results, the notation βa1b1 is used to denote the unstandardized beta coefficient for the mediating
variable representing the previously depicted a à b à Y path (i.e. indirect effect). With trait
anxiety as the antecedent variable, the indirect effect of perceived stress is statistically associated
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with CARS nature of worry (β = .5474, 95% CI = .0178 - 1.3298, p = .0294). Similarly, with the
composite age and trait anxiety antecedent variable, perceived stress is statistically associated
with concerns about recurrence nature of worry (β = 2.0375, 95% CI = .1136 - 4.5976, p =
.0495). The standardized regression coefficients for perceived stress were 2.1787 and 1.9644
respectively for the models with trait anxiety alone versus the composite z-score of age/trait
anxiety as the antecedent variable. Therefore, inclusion of age with trait anxiety had no
incremental increase in the strength of relationship with fear of recurrence (CARS nature of
worry), as well as the indirect effect of perceived stress. State anxiety, fatigue and pain were not
statistically significant, and did not provide evidence of mediating the relationship between trait
anxiety, age/trait anxiety and concerns about recurrence (CARS nature of worry).
Table 22
Indirect Effects of Antecedent Variables on Concerns About Recurrence Nature of Worry
through Mediator Variables (N = 82)
Variables
z
p-value
β Coefficient SE
Antecedent Variable
Mediator Variable
Age
State Anxiety
-.0166
.0989 -.1681
.8665
Trait Anxiety
State Anxiety
.4470
.3012 1.4844
.1377
Trait Anxiety and Age ** State Anxiety
1.5524
1.0356 1.4990
.1339
Age
Perceived Stress
-.0735
.1075 -.6837
.4941
Trait Anxiety
Perceived Stress
.5474
.2512 2.1787
.0294*
Trait Anxiety and Age** Perceived Stress
2.0375
1.0372 1.9644
.0495*
Age
Fatigue
-.0318
.0646 -.4927
.6223
Trait Anxiety
Fatigue
.0915
.0736 1.2430
.2139
Trait Anxiety and Age** Fatigue
.4804
.4076 1.1785
.2386
Age
Pain
-.0005
.0595 -.0083
.9934
Trait Anxiety
Pain
.0862
.0746 1.1563
.2476
Trait Anxiety and Age** Pain
.3867
.3656 1.0577
.2902
* p < .05.
S.E. = Standard Error
**Composite variable - converted to z-score to apply equal weight to each variable
Note: Each model evaluated separately
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Summary of Findings
After accounting for the direct effects (c' path = a, b, c paths) of trait anxiety and trait
anxiety and age combined on fear of cancer recurrence (CARS overall fear and CARS nature of
worry) two significant mediation effects were identified. This included state anxiety mediating
the relationship between trait anxiety and fear of recurrence (CARS overall fear), and perceived
stress mediating the relationship between trait anxiety and fear of recurrence (CARS nature of
worry). Whereas similar results were observed when trait anxiety and age were combined as a
composite antecedent variable, the results appeared to be driven principally by the effect of trait
anxiety with age adding little to the strength of the relationships. In aggregate, these findings
suggest that the women in this study who had a history of trait anxiety (and perhaps of younger
age) were more likely to experience fear of cancer recurrence (CARS overall) if they also were
experiencing anxious symptoms in their current state (state anxiety). Additionally, those women
in this study who had a history of trait anxiety (and perhaps of younger age) were more likely to
experience fear of cancer recurrence (CARS nature of worry) if they were also experiencing
stressful feelings about their life within the past month (perceived stress).
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Chapter Five
Discussion, Conclusions and Recommendations
Introduction
This final chapter presents the synthesis of the research results including the discussion of
the findings, conclusions, implications and recommendations for future study. This study
explored non-modifiable trait and modifiable factors state factors most associated with fear of
breast cancer recurrence and the mediating relationship between those variables. The intent was
to establish an understanding of how particular trait and state characteristics can influence a
patient’s concern about the recurrence of their cancer. Understanding this relationship supports
the opportunity for health care providers to offer interventions to those patients at risk for greater
fears of recurrence.
Summary of the Study
A cross-sectional research design was used to conduct a secondary data analysis among
82 women who were post-treatment for breast cancer. The original parent study was an R-21
NCI funded, randomized controlled intervention trial examining the Effects of Mindfulness
Based Stress Reduction in Early Stage Breast Cancer Recovery (Lengacher et al., 2009). The
current study utilizes the baseline data from the R-21 study for a secondary data analysis
examining the relationship between trait factors and state factors on fear of cancer recurrence in
breast cancer survivors.
The study sample consists of 82 out of 84 women age 21 or older who were diagnosed
with breast cancer Stage 0, I, II, III and had undergone lumpectomy and received adjuvant
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radiation and/or chemotherapy and were within 18 months post treatment. Other inclusion
criteria included the ability to read and speak English at an 8th grade level in order to respond to
survey questions. Several recruitment methods were used including introduction of the study by
healthcare practitioners at the H. Lee Moffitt Cancer Center in addition to brochures and flyers
distributed throughout the cancer center. Patients who expressed interest in the study were asked
to complete a HIPAA authorization form that indicated their willingness to be contacted by a
member of the trained research team. Interested subjects were provided with an orientation
session within 18 months post treatment for breast cancer, considered to be the transition period
from conventional treatment to the adaptation and return to routine daily life and activities.
During the orientation session study details were explained, informed consent was obtained, and
patients were randomized into the different groups (as a note, in order to maximize enrollment
subjects who were randomized to the control group were offered the opportunity to receive the
intervention after a wait period).
Discussion and Conclusion
Descriptive data were obtained for the demographics of the study sample including
frequencies, percentages, means and standard deviations. The mean age of the women in the
study was of 57 years (M = 57.18 SD + 9.136). Eighty seven percent of the study participants
were White and 12.2% were Black non-Hispanic. The majority of the women who participated in
the study were married (68.3%) and 31.7% were unmarried divorced, never married or separated.
Fifty eight percent of the women were employed at the start of the study and the majority of the
women (67.1%) reported some level of higher education (n=55) including college, graduate
school or professional school.
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Clinical history revealed that the majority of the women were diagnosed with early stages
of cancer, Stage 0 (17.1%) and Stage I (52.4%) with 59.8% received radiation only and 40.2%
received radiation and chemotherapy. Fifty-eight women reported a history of hormone use
either for fertility, contraception or hormone replacement and 14 women reported a family
history of breast cancer in a mother, grandmother, sister or aunt.
Social/Behavioral history including a history of smoking, alcohol use, beer, wine and
liquor consumption and the number of days per week exercised was also studied. The average
number of days exercised was 2.77 days per week. Of the 81 women who responded, the
majority of the women were non-smokers (53.1%), 43.2% of the women reported being a former
smoker and 3.7% were current smokers. Of the 80 responses to alcohol consumption, 49 women
(61.3%) reported drinking alcohol with wine being predominating beverage of choice over beer
and liquor.
In this study sample, the women demonstrated higher levels of perceived stress, state and
trait anxiety, and depression compared to the general population. Overall, the women in the
study experienced low pain scores and low to moderate fatigue, sleep disturbance levels and fear
of recurrence.
Research aim one explored the relationship between the antecedent variables (nonmodifiable trait factors) and fear of recurrence (CARS Overall and CARS Nature). The findings
revealed statistical significance that age was negatively associated with fear of recurrence
(CARS overall fear (r = -.236, p = 0.033) and CARS nature of worry (r = -.269, p = .015))
meaning as age increases, fear of recurrence decreases which consistent with the literature
(Connell et al., 2006; Crane-Okada et al., 2012; Janz et al., 2011; King et al., 2000; McGinty et
al., 2010; Thewes et al., 2012; Van den Beuken-van Everdingen et al., 2008; Waljee et al., 2008).
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In addition, trait anxiety was positively associated with fear of recurrence (CARS overall fear (r
= .433, p=.000) and CARS nature of worry (r = .358, p = .001)), meaning as trait anxiety
increases, fear of recurrence increases. Several studies discovered similar findings, suggesting
perhaps a bidirectional relationship between anxiety and fear of cancer recurrence (Corter et al.,
2013; Costanzo et al., 2007; Crane-Okada et al., 2012; Liu et al., 2011; Young & White, 2006;
Ziner et al., 2012). Education, stage and exercise were not found to be associated with fear of
recurrence for CARS overall worry or CARS nature of worry. The analysis of variance
(ANOVA) did not reveal any significant differences between the groups for the categorical
antecedent variables (race/ethnicity, marital status, employment, treatment type, hormone use,
family history of cancer, smoking, alcohol use) and the outcome variable fear of recurrence
(CARS overall fear and CARS nature of worry).
Research aim two used Pearson’s correlations to examine the relationship between
mediator variables (modifiable state factors) - psychological symptoms such as state anxiety,
depression, perceived stress and physiological symptoms such as pain, fatigue, sleep
disturbances and the outcome variable fear of breast cancer recurrence (CARS overall fear and
CARS nature of worry). The findings yielded statistical significance for depression (r = .347, p
= .001), state anxiety (r = .467, p = .000) and perceived stress (r = .365, p = .001) as having a
positive association with fear of recurrence (CARS overall fear). These results support findings
from several others studies that women who experience psychological distress (depression,
anxiety, perceived stress) are at greater risk for overall fear of cancer recurrence (Allen et al.,
2009; Corter et al., 2013; Costanzo et al., 2007; Crane-Okada et al., 2012; Liu et al., 2011;
Taylor et al., 2011; Young & White, 2006; Ziner et al., 2012). Analysis of fear of cancer
recurrence (CARS nature of worry) revealed statistical significance for pain (r = .220, p = .047),
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fatigue (r = .247, p = .025), state anxiety (r = .369, p = .001) and perceived stress (r = .410, p =
.000) as having a positive association. Pain and fatigue were observed to be associated with fear
of recurrence throughout the literature, sometimes referred to as “triggers” these symptoms can
create a great deal of distress for breast cancer survivors triggering fears of recurrence (Allen et
al., 2009; Clayton et al., 2006; Corter et al., 2013; Ferrell et al., 1997; Grimsbo et al., 2011; Janz
et al., 2011; Van den Beuken-van Everdingen et al., 2008; Vickberg, 2001; Young & White,
2006; Ziner et al., 2012)
Research aim three assessed mediating state variables (transient, modifiable state factors)
indirect (mediation) effect on the relationships between antecedent trait variables (stable, nonmodifiable trait factors) and the outcome variable fear of breast cancer recurrence. Antecedent
(trait) factors are assumed to have both a direct (c' path) and indirect path (a path) to the outcome
of fear of breast cancer recurrence through the mediator variable (b path).
These findings suggest a statistical significance of the indirect effect of state anxiety on
trait anxiety and the composite variable of trait anxiety/age related to fear of recurrence (CARS
overall fear). The standardized Z-scores for state anxiety were slightly increased for trait anxiety
and for the composite variable of age/trait anxiety suggesting that state anxiety is a mediator of
trait anxiety and age/trait anxiety and fear of recurrence (CARS overall fear).
The findings related to CARS nature of worry indicate that perceived stress mediates the
relationship between trait anxiety and fear of recurrence (CARS nature of worry). These findings
suggest a statistical significance of the indirect effect of perceived stress on trait anxiety and the
composite variable trait anxiety/age related to fear of recurrence (CARS nature of worry). The
standardized Z-scores for perceived stress were reduced for trait anxiety and for age/trait anxiety
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combined suggesting that perceived stress is a partial mediator of trait anxiety and age/trait
anxiety combined and fear of recurrence (CARS nature of worry).
The significance of these findings suggest that women who are anxious at baseline and
experiencing or at risk for experiencing situational anxiety are at greater risk of overall fears of
breast cancer recurrence. Given the relationship between age, trait anxiety and fear of
recurrence, younger women could be particularly vulnerable for overall fear of breast cancer
recurrence. Similarly, women who are anxious at baseline and are experiencing situations in
their life that they perceive to be stressful may be at greater risk for worries related to fear of
recurrence such as health worries, role worries, womanhood worries and death worries. As was
discussed with the relationship between trait anxiety and fear of recurrence, the findings suggest
in this study that younger survivors who are experiencing perceived stressful situations in their
life and anxiety at baseline may be at greater risk for fear of breast cancer recurrence.
The relevance of these findings rests in the research to date that has explored the
outcomes of psychological distress in cancer survivorship in relation to survivorship well-being,
quality of life and utilization of health care resources (Barsky et al., 2001; Ferrell et al., 1997; Gil
et al, 2005; Grimsbo et al., 2011; King et al., 2000; Lebel et al., 2007; Lebel et al., 2013; Taylor
et al., 2011; Vickberg, 2003; Young & White, 2006). The research to date highlights the reality
that breast cancer survivors experience life-long emotional sequelae from their cancer diagnosis
and treatment including the concerns that their cancer will return. What is less clear is how to
best prepare patients for survivorship, including evidenced based methods for risk screening
regarding those physiological and psychological traits and states, like anxiety, perceived stress
and fear of recurrence, which may have an impact on survivorship.
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In summary, this study was performed utilizing a cross-sectional quantitative research
design analyzing secondary data from a previously conducted randomized controlled trial. The
Logic Model provided a heuristic framework to examine the associations between trait factors
and state factors and the mediating effects on fear of breast cancer recurrence. Relationships
between the antecedent variables (trait factors) typically considered stable non-modifiable
attributes (demographic, clinical history, social/behavioral) with fear of recurrence (CARS
overall fear and CARS nature of worry) were examined using Pearson’s and Spearman’s
correlations and analysis of variance (ANOVA). Secondly, the relationship between the
mediator variables (state factors), typically considered to be transient and modifiable attributes
such as pain, fatigue, sleep disturbances, state anxiety, depression, perceived stress were
examined to determine their associations with fear of recurrence (CARS overall fear and CARS
nature of worry) using Pearson’s correlations. The final step of analysis employed a mediation
model to examine the indirect effects of the statistically significant modifiable state factors on
the statistically significant antecedent trait factors and fear of recurrence (CARS overall fear and
CARS nature of worry).
Limitations
This study provided preliminary findings related to factors that may interfere with the
psychological well-being and recovery of breast cancer survivors. Understanding these
relationships can help health care providers initiate meaningful interventions to optimize the
well-being and quality of life in survivorship. Limitations of this study may include:
1. The sample size of 82 women limits the strength and generalizability of the findings.
2. The study participants were a homogeneous sample of women enrolled from only one
site in the Tampa Bay area of Florida limiting the generalizability to other populations.
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3. The use of paper and pencil questionnaires may enhance measurement error.
4. The use of more discrete measurement instruments (for example: the Brief Pain Invetory)
could be used to measure physiologic symptoms (pain, fatigue, sleep disturbances).
Implications for Nursing
The findings from this study suggest that breast cancer survivors who are anxious at
baseline and report a current state of anxiety or perceived stress (current situations in their life
that are deemed to be stressful) may be at higher risk for fears of breast cancer recurrence. The
implications of this research for nursing are merely to recognize the existence of these
relationships and how they pertain to their patients. Understanding those individual patient
characteristics such as age, history of anxiety and current status of perceived stress or anxiety
and the relationship with fears of recurrence will allow nurses to offer individualized
interventions to those patients at greatest risk for psychological distress. These findings also
support the need to for further exploration of the unique survivorship needs of different patient
populations based on their demographics, social, behavioral and clinical history.
Early screening of those risk factors for fear of recurrence and identification of patients at
greatest risk along with multimodal options for intervention can optimize well-being and quality
of life thus reducing unnecessary distress. The findings add to advancing the science associated
with fear of recurrence and breast cancer survivorship. As the generation of cancer survivors
continues to grow, addressing the psychological and physiological long-term survivorship needs
becomes imperative.
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Recommendations for Future Study
The following recommendations for future research are based upon review of the relevant
research and findings from the current study:
1. Replicate this research utilizing the subscales within the CARS nature of worry scale to
further understand more specifically the mediation of effect and relationship between trait
anxiety, perceived stress and fear of recurrence.
2.

Due to the limited size and diversity of the current study sample, expanding the study of
fear of recurrence to include intervention research in ethnically diverse and international
populations at risk for fear of breast cancer recurrence.

3. Study the implementation of early screening and interventions that address, anxiety and
perceived stress, which are strongly associated with fear of breast cancer recurrence with
the goal of improving the psychological health, well-being and overall quality of life in
breast cancer survivorship.
4. Identify and test best practices for risk screening and ongoing support models that include
ongoing access to survivorship information and education, integrative/complimentary
medicine and social support programs to reduce psychological distress associated with
anxiety, perceived stress and fear of recurrence.
5. Study the effectiveness of anxiety, perceived stress and fear of recurrence intervention
programs impact on psychological distress and health care utilization.
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